<SEC-DOCUMENT>0001193125-23-155537.txt : 20230526
<SEC-HEADER>0001193125-23-155537.hdr.sgml : 20230526
<ACCEPTANCE-DATETIME>20230526170123
ACCESSION NUMBER:		0001193125-23-155537
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20230526
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230526
DATE AS OF CHANGE:		20230526

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Walgreens Boots Alliance, Inc.
		CENTRAL INDEX KEY:			0001618921
		STANDARD INDUSTRIAL CLASSIFICATION:	RETAIL-DRUG STORES AND PROPRIETARY STORES [5912]
		IRS NUMBER:				471758322
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36759
		FILM NUMBER:		23970065

	BUSINESS ADDRESS:	
		STREET 1:		108 WILMOT ROAD
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
		BUSINESS PHONE:		(847) 315-2500

	MAIL ADDRESS:	
		STREET 1:		108 WILMOT ROAD
		CITY:			DEERFIELD
		STATE:			IL
		ZIP:			60015
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d468351d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:wba="http://walgreensbootsalliance.com/20230526" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-05-26_to_2023-05-26">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-05-26_to_2023-05-26">0001618921</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="wba-20230526.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-05-26_to_2023-05-26"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-26</xbrli:startDate> <xbrli:endDate>2023-05-26</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-26</xbrli:startDate> <xbrli:endDate>2023-05-26</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A3600NotesPayableDue2025Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:A3600NotesPayableDue2025Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-26</xbrli:startDate> <xbrli:endDate>2023-05-26</xbrli:endDate> </xbrli:period> </xbrli:context> <xbrli:context id="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A2125NotesPayableDue2026Member"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001618921</xbrli:identifier> <xbrli:segment> <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:A2125NotesPayableDue2026Member</xbrldi:explicitMember> </xbrli:segment> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-05-26</xbrli:startDate> <xbrli:endDate>2023-05-26</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-05-26_to_2023-05-26">8-K</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section 13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-05-26_to_2023-05-26" format="ixt:datemonthdayyearen">May 26, 2023</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"> <ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-05-26_to_2023-05-26">WALGREENS BOOTS ALLIANCE, INC.</ix:nonNumeric> </p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-05-26_to_2023-05-26" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-05-26_to_2023-05-26">001-36759</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-05-26_to_2023-05-26">47-1758322</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Commission File<br />Number)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification Number)</p></td></tr></table> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:33%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:31%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-05-26_to_2023-05-26">108 Wilmot Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-05-26_to_2023-05-26">Deerfield</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-05-26_to_2023-05-26" format="ixt-sec:stateprovnameen">Illinois</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-05-26_to_2023-05-26">60015</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top" colspan="3"><span style="font-weight:bold">(Address of principal executive offices)</span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold">(Zip Code)</span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Registrant&#8217;s telephone number, including area code: <ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-05-26_to_2023-05-26">(847)</ix:nonNumeric> <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-05-26_to_2023-05-26">315-2500</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not Applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-05-26_to_2023-05-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-05-26_to_2023-05-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-05-26_to_2023-05-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p> <p style="margin-top:0pt; margin-bottom:0pt; margin-left:1%; font-size:10pt; font-family:Times New Roman"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-05-26_to_2023-05-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:</p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:46%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:6%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:46%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, $0.01 par value</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">WBA</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A3600NotesPayableDue2025Member">3.600% Walgreens Boots Alliance, Inc. notes due 2025</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A3600NotesPayableDue2025Member">WBA25</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A3600NotesPayableDue2025Member" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A2125NotesPayableDue2026Member">2.125% Walgreens Boots Alliance, Inc. notes due 2026</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A2125NotesPayableDue2026Member">WBA26</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A2125NotesPayableDue2026Member" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></span></td></tr></table> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:right">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-05-26_to_2023-05-26" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold"><span style="text-decoration:underline">Item</span><span style="text-decoration:underline">&#160;</span><span style="text-decoration:underline">7.01</span>.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Regulation FD Disclosure</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As previously disclosed, on March&#160;24, 2023, the putative shareholder derivative plaintiff in <span style="font-style:italic">Cutler v. Wasson et al.</span>, No. <span style="white-space:nowrap"><span style="white-space:nowrap">1:14-cv-10408</span></span> (N.D. Ill.), filed a motion for preliminary approval of a settlement resolving the litigation. On May&#160;8, 2023, the court entered an order preliminarily approving the settlement. Pursuant to that preliminary approval order, Walgreens Boots Alliance, Inc. is attaching hereto as Exhibits 99.1 and 99.2, respectively, and incorporating by reference herein, (i)&#160;the Stipulation of Settlement, dated March&#160;22, 2023, and (ii)&#160;the Amended Notice of Pendency and Proposed Settlement of Shareholder Derivative Action, preliminarily approved by the court on May&#160;8, 2023. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold"><span style="text-decoration:underline">Item</span><span style="text-decoration:underline">&#160;</span><span style="text-decoration:underline">9.01</span>.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left"><span style="text-decoration:underline">Financial Statements and Exhibits</span>. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) <span style="text-decoration:underline">Exhibits</span></p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:4%"></td>
<td style="width:93%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style="vertical-align:bottom" align="center"><span style="font-weight:bold">Exhibit</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d468351dex991.htm">Stipulation of Settlement, dated March&#160;22, 2023 </a></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.2</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d468351dex992.htm">Amended Notice of Pendency and Proposed Settlement of Shareholder Derivative Action, preliminarily approved May&#160;8, 2023 </a></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document)</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><span style="text-decoration:underline">SIGNATURE </span></p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:37%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:2%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:14%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:38%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="5" style="vertical-align:bottom;white-space:nowrap">WALGREENS BOOTS ALLIANCE, INC.</td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="4"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top">Date: May&#160;26, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Joseph B. Amsbary, Jr.</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:bottom;white-space:nowrap">Joseph B. Amsbary, Jr.</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top;white-space:nowrap">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td colspan="3" style="vertical-align:top;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Senior Vice President and</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">Corporate Secretary</p></td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d468351dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.1 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 2 of 51 PageID #:538 </FONT></P>
<P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES DISTRICT COURT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>NORTHERN DISTRICT OF ILLINOIS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>EASTERN DIVISION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">COREY CUTLER AS PERSONAL REPRESENTATIVE OF THE ESTATE OF ANNE SHIRLEY CUTLER, Derivatively on Behalf of WALGREEN CO.,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-10408</FONT></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Plaintiff,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Hon. Nancy L. Maldonado</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;v.</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">GREGORY D. WASSON, JAMES A. SKINNER, WILLIAM C. FOOTE, STEFANO PESSINA, ALAN G. MCNALLY, NANCY M. SCHLICHTING, ALEJANDRO SILVA, STEPHEN A. DAVIS, MARK P. FRISSORA, GINGER L.
GRAHAM, DAVID J. BRAILER, DOMINIC P. MURPHY, JANICE M. BABIAK, WADE D. MIQUELON, and DAVID Y. SCHWARTZ,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Defendants,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#150; and &#150;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">WALGREEN CO., a Illinois corporation,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right">Nominal
Defendant.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</P> <P STYLE="font-size:2pt; margin-top:0pt; margin-bottom:1pt" align="left">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><U>STIPULATION OF SETTLEMENT </U></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 3 of 51 PageID #:539
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">This Stipulation of Settlement, dated March&nbsp;22, 2023 (the &#147;Stipulation&#148;), is made and entered into by and among
the following settling parties, by and through their respective counsel of record: (i)&nbsp;plaintiff Corey Cutler as Personal Representative of the Estate of Anne Shirley Cutler (&#147;Plaintiff&#148;); (ii) Gregory D. Wasson, James A. Skinner,
William C. Foote, Stefano Pessina, Alan G. McNally, Nancy M. Schlichting, Alejandro Silva, Stephen A. Davis, Mark P. Frissora, Ginger L. Graham, David J. Brailer, Dominic P. Murphy, Janice M. Babiak, Wade D. Miquelon, and David Y. Schwartz
(collectively, the &#147;Individual Defendants&#148;); and (iii)&nbsp;nominal defendant Walgreen Co. (&#147;Walgreens&#148; or the &#147;Company&#148;) (collectively, the &#147;Parties&#148;). This Stipulation is intended by the Parties to fully,
finally, and forever resolve, discharge, and settle the Released Claims, subject to the terms and conditions set forth herein.<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>I.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>FACTUAL AND PROCEDURAL BACKGROUND </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Proceedings in this Derivative Action </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">On December&nbsp;29, 2014, Anne Cutler<SUP STYLE="font-size:75%; vertical-align:top">2</SUP> filed a shareholder derivative
complaint (&#147;Complaint&#148;) derivatively on behalf of Walgreens against certain of the Company&#146;s current and former officers and directors for alleged breaches of fiduciary duty, waste of corporate assets, and unjust enrichment in
connection with their alleged failure to disclose material information concerning the Company&#146;s future business prospects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Defendants filed motions to dismiss the Complaint on April&nbsp;10, 2015 (Dkt. 35, 37) and a motion for a protective order
staying discovery on April&nbsp;13, 2015 (Dkt. 39). </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:24%">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> All capitalized terms not otherwise defined are defined in section IV.1. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><SUP
STYLE="font-size:75%; vertical-align:top">2</SUP> Anne Cutler died on November&nbsp;4, 2018. On May&nbsp;31, 2019, the Court granted Plaintiff&#146;s motion to substitute Ms.&nbsp;Cutler&#146;s son, Corey Cutler, as Personal Representative of the
Estate of Anne Shirley Cutler. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 1 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 4 of 51 PageID #:540
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The Parties then engaged in discussions regarding scheduling and the coordination of this derivative action with the related
Securities Action (defined below). On May&nbsp;18, 2015, the Court entered an order approving the Parties&#146; stipulation to stay this shareholder derivative action pending resolution of the motion to dismiss the Securities Action (Dkt. 45).
Thereafter, on November&nbsp;3, 2016, the Court entered an order approving the parties&#146; stipulation to stay this action pending final resolution of the Securities Action (Dkt. 59). </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Proceedings in the Related Securities Action </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The alleged misstatements caused Walgreens, as well as certain of its officers, to be named in a federal securities fraud class
action, titled <I>Washtenaw County Employees&#146; Retirement System v. Walgreen Co.</I>, Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:15-cv-03187,</FONT></FONT> which was pending before this Court (the
&#147;Securities Action&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">On March&nbsp;5, 2021, after the completion of fact and expert discovery, the Securities
Action defendants filed a motion for summary judgment and the Securities Action lead plaintiff filed a motion for partial summary judgment. On November&nbsp;2, 2021, the Court entered an order denying lead plaintiff&#146;s motion and granting in
part and denying in part defendants&#146; motion. On November&nbsp;18, 2021, defendants filed a motion requesting partial reconsideration of the Court&#146;s November&nbsp;2 order or, alternatively, certification of an interlocutory appeal. On
March&nbsp;2, 2022, the Court entered an order granting defendants&#146; motion for reconsideration. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Shortly thereafter,
the parties to the Securities Action reached an agreement to settle that action, which was approved by the Court on October&nbsp;13, 2022. <B></B> </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>C.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Settlement Efforts </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Shortly after the Court granted the defendants&#146; motion for reconsideration in the Securities Action, the Parties commenced
negotiations to settle this Action. The Parties engaged in significant <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiations regarding certain corporate governance reforms with the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 5 of 51 PageID #:541
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">supervision and assistance of highly-experienced and well-respected mediators Hon. Layn R. Phillips (Ret.) and Niki Mendoza from Phillips ADR.
After several months, during which the Parties exchanged proposals and counter-proposals and Plaintiff&#146;s Counsel reviewed the Company&#146;s pertinent <FONT STYLE="white-space:nowrap">non-public</FONT> disclosure policies, the Parties reached
an agreement on the Reforms (defined below) to be implemented as part of the proposed Settlement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Thereafter, the Parties
negotiated the formal operative terms of the Settlement as set forth in this Stipulation and commenced <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiations regarding an appropriate amount of attorneys&#146; fees and expenses to be
paid to Plaintiff&#146;s Counsel in recognition of the benefits conferred by this Settlement. The fee negotiations were facilitated and supervised by mediator Niki Mendoza and culminated in the Parties&#146; agreement to a Fee and Expense Amount of
$950,000, subject to Court approval. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>II.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>PLAINTIFF&#146;S CLAIMS AND THE BENEFITS OF SETTLEMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Plaintiff believes that the Action has substantial merit, and Plaintiff&#146;s entry into this Stipulation and Settlement is
not intended to be and shall not be construed as an admission or concession concerning the relative strength or merit of the claims alleged in the Action. However, Plaintiff and Plaintiff&#146;s Counsel recognize and acknowledge the significant
risk, expense, and length of continued proceedings necessary to prosecute the Action against the Individual Defendants through trial and possible appeals. Plaintiff&#146;s Counsel have also taken into account the uncertain outcome and the risk of
any litigation, especially in complex cases such as the Action, as well as the difficulties and delays inherent in such litigation. Plaintiff&#146;s Counsel are also mindful of the inherent problems of establishing standing to pursue this derivative
action, and the possible defenses to the claims alleged. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Plaintiff&#146;s Counsel have conducted extensive investigation
and analysis, including, <I>inter alia</I>: (i)&nbsp;reviewing Walgreens&#146;<B> </B>press releases, public statements, U.S. Securities and Exchange </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 6 of 51 PageID #:542
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Commission (&#147;SEC&#148;) filings, and securities analysts&#146; reports and advisories about the Company; (ii)&nbsp;reviewing related media
reports about the Company; (iii)&nbsp;reviewing <FONT STYLE="white-space:nowrap">non-public</FONT> documents produced in connection with the related Securities Action; (iv)&nbsp;researching applicable law with respect to the claims alleged in the
Action and potential defenses thereto; (iv)&nbsp;reviewing and analyzing the allegations and pleadings filed in the related Securities Action; (v)&nbsp;preparing and filing a derivative complaint; (vi)&nbsp;conducting damages analyses; and
(vii)&nbsp;negotiating this Settlement with Defendants, including researching corporate governance best practices and negotiating the Reforms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Based on Plaintiff&#146;s Counsel&#146;s thorough review and analysis of the relevant facts, allegations, defenses, and
controlling legal principles, Plaintiff&#146;s Counsel believe that the Settlement set forth in this Stipulation is fair, reasonable, and adequate, and confers substantial benefits upon Walgreens. Based upon Plaintiff&#146;s Counsel&#146;s
evaluation, Plaintiff has determined that it believes the Settlement is in the best interests of Walgreens<B> </B>and has agreed to settle the Action upon the terms and subject to the conditions set forth herein. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>III.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B>DEFENDANTS&#146; DENIALS OF WRONGDOING AND LIABILITY </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Defendants have denied and continue to deny each and all of the claims alleged by Plaintiff in the Action, including that there
was any wrongdoing, any liability, or any harm to Walgreens. In particular, the Individual Defendants have expressly denied and continue to deny all charges of wrongdoing or liability against them, and any harm to Walgreens, arising out of any of
the conduct, statements, acts, or omissions alleged, or that could have been alleged, in the Action. Nonetheless, Defendants have concluded that further litigation would be protracted, expensive, and distracting, and have also taken into account the
uncertainty and risks inherent in any litigation, especially in complex cases like the Action. Defendants have, therefore, determined that the Settlement confers a substantial benefit upon Walgreens and its shareholders, and the Settlement, and each
of its terms, is in all respects fair, reasonable, and in the best interests of Walgreens and its shareholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 7 of 51 PageID #:543
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Neither this Stipulation, nor any of its terms or provisions, nor entry of the Judgment, nor any document or exhibit referred
or attached to this Stipulation, nor any action taken to carry out this Stipulation, is, may be construed as, or may be used as evidence of the validity of any of the Released Claims or an admission by or against any of the Defendants of any fault,
wrongdoing, or concession of liability whatsoever. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>IV.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>TERMS OF STIPULATION AND AGREEMENT OF SETTLEMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">NOW, THEREFORE, IT IS HEREBY STIPULATED AND AGREED by and among the undersigned counsel for the Parties herein, in
consideration of the benefits flowing to the Parties from the Settlement, and subject to the approval of the Court, that the Released Claims shall be finally and fully compromised, settled, and released, and the Action shall be dismissed with
prejudice and with full preclusive effect, upon and subject to the terms and conditions of this Stipulation, as set forth below. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>1.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Definitions </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">As used in this Stipulation, the following terms have the meanings specified below: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.1&nbsp;&nbsp;&nbsp;&nbsp; &#147;Action&#148; means this the derivative action styled as <I>Cutler v. Wasson, et al.</I>, Case
No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-10408.</FONT></FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.2&nbsp;&nbsp;&nbsp;&nbsp; &#147;Court&#148; means U.S. District Court for the Northern District of Illinois. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.3&nbsp;&nbsp;&nbsp;&nbsp; &#147;Current Walgreens<B> </B>Shareholders&#148; means any Person who owned common stock of
Walgreens<B> </B>as of the date of the execution of this Stipulation and continues to hold their Walgreens<B> </B>common stock as of the date of Settlement Hearing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.4&nbsp;&nbsp;&nbsp;&nbsp; &#147;Defendants&#148; means, collectively, nominal defendant Walgreens<B> </B>and the Individual
Defendants. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 8 of 51 PageID #:544
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.5&nbsp;&nbsp;&nbsp;&nbsp; &#147;Defendants&#146; Counsel&#148; means Sidley Austin LLP, Riley Safer Holmes&nbsp;&amp; Cancila
LLP, Wilson Sonsini Goodrich&nbsp;&amp; Rosati, and Laurence H. Levine Law Offices. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.6&nbsp;&nbsp;&nbsp;&nbsp;
&#147;Effective Date&#148; means the date by which the events and conditions specified in paragraph 6.1 of this Stipulation have all been met and/or have occurred. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.7&nbsp;&nbsp;&nbsp;&nbsp; &#147;Final&#148; means the date upon which the last of the following shall occur with respect to
the Judgment approving this Stipulation, substantially in the form of Exhibit D attached hereto: (1)&nbsp;the expiration of the time to file a notice of appeal from the Judgment; or (2)&nbsp;if an appeal has been filed, the court of appeals has
either affirmed the Judgment or dismissed that appeal and the time for any reconsideration or further appellate review has passed; or (3)&nbsp;if a higher court has granted further appellate review, that court has either affirmed the underlying
Judgment or affirmed the court of appeal&#146;s decision affirming the Judgment or dismissing the appeal. For purposes of this paragraph, an &#147;appeal&#148; shall not include any appeal that concerns only the issue of attorneys&#146; fees and
expenses or the payment of a service award. Any proceeding or order, or any appeal or petition for a writ of certiorari pertaining solely to the application for attorneys&#146; fees, costs, or expenses, or the payment of a service award, shall not
in any way delay or preclude the Judgment from becoming Final. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.8&nbsp;&nbsp;&nbsp;&nbsp; &#147;Individual
Defendants&#148; means Gregory D. Wasson, James A. Skinner, William C. Foote, Stefano Pessina, Alan G. McNally, Nancy M. Schlichting, Alejandro Silva, Stephen A. Davis, Mark P. Frissora, Ginger L. Graham, David J. Brailer, Dominic P. Murphy, Janice
M. Babiak, Wade D. Miquelon, and David Y. Schwartz. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.9&nbsp;&nbsp;&nbsp;&nbsp; &#147;Judgment&#148; means the Order and
Final Judgment to be entered by the Court, substantially in the form attached hereto as Exhibit D. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 9 of 51 PageID #:545
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.10&nbsp;&nbsp;&nbsp;&nbsp; &#147;Notice&#148; means the Notice of Proposed Settlement and of Settlement Hearing,
substantially in the form attached hereto as Exhibit C. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.11&nbsp;&nbsp;&nbsp;&nbsp; &#147;Parties&#148; means,
collectively, Plaintiff and Defendants. &#147;Party&#148; means, individually, any of the Parties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.12&nbsp;&nbsp;&nbsp;&nbsp; &#147;Person&#148; means an individual or legal entity, including any corporation, limited
liability corporation, professional corporation, partnership, limited partnership, limited liability partnership, association, joint stock company, estate, legal representative, trust, unincorporated association, government or any political
subdivision or agency thereof and any business or legal entity and their spouses, heirs, predecessors, successors, representatives, or assignees. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.13&nbsp;&nbsp;&nbsp;&nbsp; &#147;Plaintiff&#148; means Corey Cutler as Personal Representative of the Estate of Anne Shirley
Cutler. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.14&nbsp;&nbsp;&nbsp;&nbsp; &#147;Plaintiff&#146;s Counsel&#148; means Robbins LLP, Vita Law Offices, P.C., and
Law Offices of Norman Rifkind. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.15&nbsp;&nbsp;&nbsp;&nbsp; &#147;Related Persons&#148; means: (i)&nbsp;with regard to
each Individual Defendant, the Individual Defendants&#146; spouses, marital communities, immediate family members, heirs, executors, personal representatives, estates, administrators, trusts, predecessors, successors, and assigns or other individual
or entity in which any Individual Defendant has a controlling interest, and each and all of their respective past and present officers, directors, employees, agents, affiliates, parents, subsidiaries, divisions, attorneys, accountants, auditors,
advisors, insurers, <FONT STYLE="white-space:nowrap">co-insurers,</FONT> <FONT STYLE="white-space:nowrap">re-insurers,</FONT> heirs, executors, personal representatives, estates, administrators, trusts, predecessors, successors, and assigns; and
(ii)&nbsp;with regard to Walgreens, all past or present agents, officers, directors, attorneys, accountants, auditors, advisors, insurers, <FONT STYLE="white-space:nowrap">co-insurers,</FONT> reinsurers, partners, controlling shareholders, joint
venturers, related or affiliated entities, advisors, employees, affiliates, predecessors, successors, parents, subsidiaries, insurers, and assigns. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 7 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 10 of 51 PageID #:546
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.16&nbsp;&nbsp;&nbsp;&nbsp; &#147;Released Claims&#148; means any and all actions, suits, claims, debts, rights, liabilities,
and causes of action of every nature, including both known and Unknown Claims (as defined in paragraph 1.22 below), existing derivatively on behalf of Walgreens or by Walgreens, that were asserted in this Action, could have been asserted in this
Action, or in the future are asserted derivatively on behalf of Walgreens or by Walgreens against any of its current or former directors, officers, or employees,<B> </B>that arise out of, are based on, or relate to in any way: (i)&nbsp;the matters
and events referenced in this Action or the factually-related Securities Action, including any pleading or other document filed in this Action; or (ii)&nbsp;the Settlement, except for any claims to enforce the Settlement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.17&nbsp;&nbsp;&nbsp;&nbsp; &#147;Released Persons&#148; means, collectively, Walgreens, the Individual Defendants, and their
Related Persons. &#147;Released Person&#148; means, individually, any of the Released Persons. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.18&nbsp;&nbsp;&nbsp;&nbsp; &#147;Releasing Parties&#148; means Plaintiff, all other Current Walgreens<B> </B>Shareholders,
Plaintiff&#146;s Counsel, and Walgreens. &#147;Releasing Party&#148; means, individually, any of the Releasing Parties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.19&nbsp;&nbsp;&nbsp;&nbsp; &#147;Securities Action&#148; means the securities class action styled as <I>Washtenaw County
Employees&#146; Retirement System v. Walgreen Co.</I>, Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:15-cv-03187,</FONT></FONT> which was pending in this Court. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.20&nbsp;&nbsp;&nbsp;&nbsp; &#147;Settlement&#148; means the settlement and compromise of the Action as provided for herein.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.21&nbsp;&nbsp;&nbsp;&nbsp; &#147;Settlement Hearing&#148; means the hearing or hearings at which the Court will
determine whether the Settlement should be approved and the Judgment entered. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 8 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 11 of 51 PageID #:547
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.22&nbsp;&nbsp;&nbsp;&nbsp; &#147;Unknown Claims&#148; means any Released Claim(s) which Plaintiff, any Walgreens Shareholder,
or Defendants do not know of or suspect to exist in their favor at the time of the release of the Released Persons that, if known, would have materially affected this Settlement or a decision not to object to this Settlement. With respect to any and
all Released Claims, the Parties agree that upon the Effective Date, the Parties expressly waive, and Current Walgreens Shareholders shall be deemed to have waived, the provisions, rights and benefits conferred by or under California Civil Code
section 1542, or any other law of the United States or any state or territory of the United States, or principle of common law, which is similar, comparable, or equivalent to section 1542, which provides: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; margin-right:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR OR RELEASING PARTY DOES NOT KNOW OR SUSPECT TO
EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE AND THAT, IF KNOWN BY HIM OR HER, WOULD HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR OR RELEASED PARTY. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The Parties acknowledge that they may hereafter discover facts in addition to or different from those now known or believed to
be true by them, with respect to the subject matter of the Released Claims, but it is the intention of the Parties to completely, fully, finally, and forever compromise, settle, release, discharge, and extinguish any and all Released Claims, known
or unknown, suspected or unsuspected, contingent or absolute, accrued or unaccrued, apparent or unapparent, which do now exist, or heretofore existed, or may hereafter exist, and without regard to the subsequent discovery of additional or different
facts. Plaintiff, Walgreens, and every Current Walgreens Shareholder shall be deemed by operation of the Judgment to have acknowledged that the foregoing waiver and release of Unknown Claims was separately bargained for and is a key element of the
Settlement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 9 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 12 of 51 PageID #:548
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.23&nbsp;&nbsp;&nbsp;&nbsp; &#147;Walgreens&#148; or the &#147;Company&#148; means nominal defendant Walgreen Co., an
Illinois<B> </B>corporation, and its affiliates, subsidiaries, predecessors, successors, and assigns. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>2.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Terms of the Settlement </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">2.1&nbsp;&nbsp;&nbsp;&nbsp; As a result of the filing, prosecution, and settlement of the Action, Walgreens<B> </B>shall,
within sixty (60)<B></B>&nbsp;days of the Effective Date, adopt and take such actions as are necessary to implement or initiate, as appropriate, the corporate governance reforms identified in Exhibit A (&#147;Reforms&#148;) attached hereto, for a
period of no less than five (5)<B></B>&nbsp;years. Walgreens<B> </B>acknowledges that, unless otherwise stated in Exhibit A, the prosecution and settlement of the Action was the sole factor<B> </B>in the agreement to adopt and/or implement the
Reforms. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>3.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Approval and Notice </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">3.1&nbsp;&nbsp;&nbsp;&nbsp; Promptly after execution of this Stipulation, the Parties shall submit this Stipulation together
with its exhibits to the Court and shall jointly apply for entry of an order (the &#147;Preliminary Approval Order&#148;), substantially in the form of Exhibit B attached hereto, requesting: (i)&nbsp;preliminary approval of the Settlement set forth
in this Stipulation; (ii)&nbsp;approval of the form and manner of providing notice of the settlement to Current Walgreens Shareholders; and (iii)&nbsp;a date for the Settlement Hearing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">3.2&nbsp;&nbsp;&nbsp;&nbsp; Notice to Current Walgreens Shareholders shall consist of the Notice, which includes the general
terms of the Settlement set forth in this Stipulation and the date of the Settlement Hearing, substantially in the form attached hereto as Exhibit C. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">3.3&nbsp;&nbsp;&nbsp;&nbsp; Walgreens shall undertake the administrative responsibility for giving notice to Current Walgreens
Shareholders and shall be solely responsible for paying the costs and expenses related to providing such notice to its shareholders. Within 15 business days after the entry of the Preliminary Approval Order, Walgreens shall cause the Stipulation and
Notice to be filed with the SEC on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> and Walgreens shall post a link to the Stipulation and Notice on the &#147;Investor </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 10 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 13 of 51 PageID #:549
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Relations&#148; page of Walgreens&#146; website, the address of which shall be contained in the Notice. If additional notice is required by the
Court, then the cost and administration of such additional notice will be borne by Walgreens. The Parties believe the content and manner of notice, as set forth in this paragraph, constitutes adequate and reasonable notice to Current Walgreens
Shareholders pursuant to applicable law and due process. Prior to the Settlement Hearing, Defendants&#146; Counsel shall file with the Court an appropriate declaration with respect to compliance with this paragraph. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">3.4&nbsp;&nbsp;&nbsp;&nbsp; Pending the Effective Date, Plaintiff and Plaintiff&#146;s Counsel are barred and enjoined from
commencing, prosecuting, instigating, or in any way participating in the commencement or prosecution of any action, including this Action, asserting any Released Claim against any of the Released Persons. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>4.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Attorneys&#146; Fees and Reimbursement of Expenses </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">4.1&nbsp;&nbsp;&nbsp;&nbsp; In recognition of the substantial benefits conferred upon the Company as a result of the
Settlement, and subject to Court approval, Walgreens and/or the Defendants&#146; insurers agreed to pay Plaintiff&#146;s Counsel&#146;s attorneys&#146; fees and expenses in the total amount of $950,000<B> </B>(the &#147;Fee and Expense
Amount&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">4.2&nbsp;&nbsp;&nbsp;&nbsp; The Fee and Expense Amount or such other amount as may be awarded by the Court
shall constitute final and complete payment for Plaintiff&#146;s attorneys&#146; fees and expenses that have been incurred or will be incurred in connection with the Action. If the court awards fees and expenses not exceeding the Fee and Expense
Amount, Walgreens shall pay, or shall cause its insurer(s) to pay, the awarded amount into an escrow account controlled by Robbins LLP within twenty (20)&nbsp;business days of the later of (i)&nbsp;entry of the Preliminary Approval Order and
(ii)&nbsp;provision by Plaintiff&#146;s Counsel of all funding information and tax identification numbers required by Walgreens, and shall be immediately releasable upon entry of the Judgment and an order approving the Fee and Expense Amount or such
other amount as may be awarded by the Court, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 11 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 14 of 51 PageID #:550
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">notwithstanding the existence of any timely filed objections thereto, or potential for appeal therefrom, or collateral attack on the Settlement
or any part thereof. Plaintiff&#146;s Counsel shall be severally obligated to make refunds or repayment of all amounts received, directly to the funding Person and within twenty business days of receiving a written request, if any specified
condition to the Settlement is not satisfied or, as a result of any appeal and/or further proceedings on remand, or successful collateral attack, the Court&#146;s approval of the Settlement is reversed, or the Fee and Expense Amount is reduced or
reversed, or the Effective Date for any reason does not occur. Other than Walgreens&#146; obligation to pay or cause to be paid an amount not exceeding the Fee and Expense Amount and the costs of providing notice of the Settlement, neither the
Defendants nor any other Released Person shall have any obligations to make any other payment pursuant to this Stipulation, and shall not have any responsibility, obligation, or liability with respect to the escrow account controlled by Robbins LLP
or the monies maintained therein or the administration related to the Fee and Expense Amount, including, without limitation, any responsibility or liability related to allocation of the Fee and Expense Amount, any fees, taxes, investment decisions,
maintenance, supervision, or distribution of any portion of the Fee and Expense Amount. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">4.3&nbsp;&nbsp;&nbsp;&nbsp; The
Parties further stipulate that Plaintiff&#146;s Counsel may apply to the Court for a service award of up to $2,500<B> </B>for Plaintiff (the &#147;Service Award&#148;), only to be paid upon Court approval, and to be paid from Plaintiff&#146;s
Counsel&#146;s Fee and Expense Amount in recognition of Plaintiff&#146;s participation and effort in the prosecution of the Action. The failure of the Court to approve any requested Service Award, in whole or in part, shall have no effect on the
Settlement set forth in this Stipulation. Neither Walgreens<B> </B>nor any of the Individual Defendants shall be liable for any portion of any Service Award. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 12 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 15 of 51 PageID #:551
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>5.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Releases </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">5.1&nbsp;&nbsp;&nbsp;&nbsp; Upon the Effective Date, the Releasing Parties shall be deemed to have fully, finally, and forever
released, relinquished, and discharged the Released Claims (including Unknown Claims) against the Released Persons, and any and all claims arising out of, relating to, or in connection with the defense, settlement, or resolution of the Action
against the Released Persons. Nothing herein shall in any way impair or restrict the rights of any Party to enforce the terms of this Stipulation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">5.2&nbsp;&nbsp;&nbsp;&nbsp; Upon the Effective Date, each of the Defendants shall be deemed to have fully, finally, and forever
released, relinquished, and discharged Plaintiff and Plaintiff&#146;s Counsel from all claims (including Unknown Claims), arising out of, relating to, or in connection with the institution, prosecution, assertion, settlement, or resolution of the
Action or the Released Claims. Nothing herein shall in any way impair or restrict the rights of any Party to enforce the terms of this Stipulation. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>6.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Conditions of Settlement; Effect of Disapproval, Cancellation, or Termination </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">6.1&nbsp;&nbsp;&nbsp;&nbsp; The Effective Date of this Stipulation shall be conditioned on the occurrence of all of the
following events: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">a.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Court approval of the Settlement in all material respects; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">b.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Court entry of the Judgment in all material respects; and </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">c.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">the passing of the date upon which the Judgment becomes Final. </P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">6.2&nbsp;&nbsp;&nbsp;&nbsp; If any of the conditions specified above in paragraph 6.1 are not met, then this Stipulation shall
be canceled and terminated subject to paragraph 6.3, unless counsel for the Parties mutually agree in writing to proceed with this Stipulation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">6.3&nbsp;&nbsp;&nbsp;&nbsp; If for any reason the Effective Date of this Stipulation does not occur, or if this Stipulation is
in any way canceled, terminated, or fails to become Final in accordance with its </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 13 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 16 of 51 PageID #:552
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">terms: (a)&nbsp;all Parties and Released Persons shall be restored to their respective positions in the Action as of the execution date of this
Stipulation; (b)&nbsp;all releases delivered in connection with this Stipulation shall be null and void, except as otherwise provided for in this Stipulation; (c)&nbsp;the Fee and Expense Amount or any other amount paid to Plaintiff&#146;s Counsel
shall be refunded and returned within twenty (20)&nbsp;business days after receiving a written request from Walgreens; and (d)&nbsp;all negotiations, proceedings, documents prepared, and statements made in connection herewith shall be without
prejudice to the Parties, shall not be deemed or construed to be an admission by a Party of any act, matter, or proposition, and shall not be used in any manner for any purpose in any subsequent proceeding in the Action or in any other action or
proceeding. In such event, the terms and provisions of this Stipulation shall have no further force and effect with respect to the Parties and shall not be used in the Action or in any other proceeding for any purpose. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">6.4&nbsp;&nbsp;&nbsp;&nbsp; No order of the Court concerning the Fee and Expense Amount or the Service Award that awards
amounts at or below those stated in paragraphs 4.1 and 4.3 (and no modification, or reversal on appeal of any order concerning the Fee and Expense Amount or the Service Award) shall constitute grounds for cancellation or termination of the
Stipulation, affect the enforceability of the Stipulation, or delay or preclude the Judgment from becoming Final. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>7.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Miscellaneous Provisions </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.1&nbsp;&nbsp;&nbsp;&nbsp; The Parties: (a)&nbsp;acknowledge that it is their intent to consummate this Stipulation; and
(b)&nbsp;agree to act in good faith and cooperate to take all reasonable and necessary steps to expeditiously implement the terms and conditions of this Stipulation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.2&nbsp;&nbsp;&nbsp;&nbsp; In the event that any part of the Settlement is found to be unlawful, void, unconscionable, or
against public policy by a court of competent jurisdiction, the remaining terms and conditions of the Settlement shall remain intact. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 14 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 17 of 51 PageID #:553
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.3&nbsp;&nbsp;&nbsp;&nbsp; The Parties intend this Settlement to be a final and complete resolution of all disputes with
respect to the Action. The Settlement comprises claims that are contested and shall not be deemed an admission by any Party as to the merits of any claim, allegation, or defense. The Parties and their respective counsel agree that at all times
during the course of the litigation, each has complied with the requirements of the applicable laws and rules of the Court, including, without limitation, Rule 11 of the Federal Rules of Civil Procedure<B> </B>and all other similar laws and/or rules
governing professional conduct. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.4&nbsp;&nbsp;&nbsp;&nbsp; Each of the Defendants expressly denies and continues to deny
all allegations of wrongdoing or liability against themselves arising out of any conduct, statements, acts, or omissions alleged, or which could have been alleged, in the Action. The existence of the provisions contained in this Stipulation shall
not be deemed to prejudice in any way the respective positions of the Parties with respect to the Action, shall not be deemed a presumption, a concession, or admission by any of the Parties of any fault, liability, or wrongdoing as to any facts,
claims, or defenses that have been or might have been alleged or asserted in the Action or with respect to any of the claims settled in the Action, or any other action or proceeding, and shall not be interpreted, construed, deemed, invoked, offered,
or received in evidence or otherwise used by any person in the Action, or in any other action or proceeding, except for any litigation or judicial proceeding arising out of or relating to this Stipulation or the Settlement whether civil, criminal,
or administrative, for any purpose other than as provided expressly herein. For the avoidance of doubt, any Party may file this Stipulation and any related documents to enforce the provisions of this Stipulation, including the releases provided for
herein. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.5&nbsp;&nbsp;&nbsp;&nbsp; This Stipulation may be modified or amended only by a writing signed by the
signatories hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 15 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 18 of 51 PageID #:554
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.6&nbsp;&nbsp;&nbsp;&nbsp; This Stipulation shall be deemed drafted equally by all Parties. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.7&nbsp;&nbsp;&nbsp;&nbsp; No representations, warranties, or inducements have been made to any of the Parties concerning this
Stipulation or its exhibits other than the representations, warranties, and covenants contained and memorialized in such documents. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.8&nbsp;&nbsp;&nbsp;&nbsp; Each counsel or other Person executing this Stipulation or its exhibits on behalf of any of the
Parties hereby warrants that such Person has the full authority to do so. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.9&nbsp;&nbsp;&nbsp;&nbsp; The exhibits to this
Stipulation are material and integral parts hereof and are fully incorporated herein by this reference. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.10&nbsp;&nbsp;&nbsp;&nbsp; This Stipulation and the exhibits attached hereto constitute the entire agreement among the
Parties with respect to the subject matter hereof and supersede all prior and contemporaneous oral and written agreements and discussions. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.11&nbsp;&nbsp;&nbsp;&nbsp; In the event that there exists a conflict or inconsistency between the terms of this Stipulation
and the terms of any exhibit hereto, the terms of this Stipulation shall prevail. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.12&nbsp;&nbsp;&nbsp;&nbsp; This
Stipulation may be executed in one or more counterparts, including by electronic signature in PDF files exchanged by email. Each counterpart, when so executed, shall be deemed to be an original, and all such counterparts together shall constitute
the same instrument. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.13&nbsp;&nbsp;&nbsp;&nbsp; This Stipulation shall be considered to have been negotiated, executed,
and delivered, and to be wholly performed, in the State of Illinois, and the rights and obligations of the parties to this Stipulation shall be construed and enforced in accordance with, and governed by, the internal, substantive laws of the State
of Illinois without giving effect to that State&#146;s choice of law principles. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 16 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 19 of 51 PageID #:555
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.14&nbsp;&nbsp;&nbsp;&nbsp; Any dispute between the Parties arising out of or relating to the Settlement shall be resolved by
a mediator from Phillips ADR, first by way of mediation and, if unsuccessful, then by way of final, binding, <FONT STYLE="white-space:nowrap">non-appealable</FONT> resolution. <B></B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.15&nbsp;&nbsp;&nbsp;&nbsp; The Court shall retain jurisdiction to implement and enforce the terms of the Stipulation and the
Court&#146;s Judgment, and the Parties submit to the jurisdiction of the Court for purposes of implementing and enforcing the Settlement embodied in the Stipulation and Judgment. <B></B> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">IN WITNESS WHEREOF, the Parties have caused this Stipulation to be executed by their duly authorized attorneys. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">SIDLEY AUSTIN LLP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">ROBBINS LLP</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"><I><U>/s/ James W.
Ducayet&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I><U>/s/ Ashley R.
Rifkin&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</U></I></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">JAMES W. DUCAYET (No. 6236997)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">ASHLEY R. RIFKIN*</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">KRISTEN R. SEEGER (No. 6278416)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">KEVIN A. SEELY (No. 199982)</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">JOHN M. SKAKUN III (No. 6297636)</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">BRIAN J. ROBBINS</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">One South Dearborn Street</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">5060 Shoreham Place, Suite 300</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">Chicago, IL 60603</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">San Diego, CA 92122</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">Telephone: (312) <FONT STYLE="white-space:nowrap">853-7000</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Telephone: (619) <FONT STYLE="white-space:nowrap">525-3990</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">Facsimile: (312) <FONT STYLE="white-space:nowrap">853-7036</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Facsimile: (619) <FONT STYLE="white-space:nowrap">525-3991</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">jducayet@sidley.com</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">arifkin@robbinsllp.com</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">kseeger@sidley.com</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">kseely@robbinsllp.com</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">jskakun@sidley.com</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">brobbins@robbinsllp.com</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"><I>Counsel for Nominal Defendant</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">*admitted <I>pro hac vice </I></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"><I>Walgreen Co.</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">LAW OFFICES OF NORMAN RIFKIND</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" ROWSPAN="2"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">RILEY SAFER HOLMES&nbsp;&amp;<BR>CANCILA LLP</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">NORMAN RIFKIND</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">100 East Huron, #1306</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chicago, IL 60611</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"><I><U>/s/ Thomas B.
Quinn&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Telephone: (847) <FONT STYLE="white-space:nowrap">372-4747</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">THOMAS B. QUINN</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">ELI LITOFF</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">VITA LAW OFFICES P.C.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">AMY C. ANDREWS</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">RICHARD J. VITA</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">Three First National Plaza</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">100 State Street, 9th Floor</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">70 West Madison St. Suite 2900</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Boston, MA 02109</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">Chicago, IL 60602</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Telephone: (617) <FONT STYLE="white-space:nowrap">426-6566</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom">Telephone: (312) <FONT STYLE="white-space:nowrap">471-8770</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Facsimile: (617) <FONT STYLE="white-space:nowrap">249-2119</FONT></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 17 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 20 of 51 PageID #:556
</FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">tquinn@rshc-law.com</FONT></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">elitoff@rshc-law.com</FONT></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><FONT
STYLE="white-space:nowrap">aandrews@rshc-law.com</FONT></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman"><I>Counsel for Defendants
Gregory D. Wasson, James A. Skinner, William C. Foote, Stefano Pessina, Alan G. McNally, Nancy M. Schlichting, Alejandro Silva, Steven A. Davis, Mark P. Frissora, Ginger L. Graham, David J. Brailer, Dominic P. Murphy, Janice M. Babiak, and David Y.
Schwartz</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman">rjv@vitalaw.com</P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman"><I>Counsel for Plaintiff Corey Cutler as Personal Representative of the Estate of Anne Shirley Cutler</I></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">WILSON SONSINI GOODRICH&nbsp;&amp;<BR>ROSATI</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman"><I>&nbsp;/s/ Caz Hashemi</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">CAZ HASHEMI</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">JESSICA L. SNORGRASS*</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">650 Page Mill Road</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Palo Alto, CA 94304</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Telephone: (650) <FONT STYLE="white-space:nowrap">493-9300</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">chashemi@wsgr.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">jsnorgrass@wsgr.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">*admitted <I>pro hac vice </I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">LAURENCE H. LEVINE LAW OFFICES</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">LAURENCE H. LEVINE</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">189 East Lake Shore Drive</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">16th Floor</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Chicago, IL 60611</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">Telephone: (312) <FONT STYLE="white-space:nowrap">927-0625</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">laurence.levine@lhlevine.com</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman"><I>Counsel for Defendant Wade D. Miquelon</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">1611341 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 18 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 21 of 51 PageID #:557
</FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"> </P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:72pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT A </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 22 of 51 PageID #:558
</FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><I>Cutler v. Wasson et al. </I></B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Walgreen Co. Derivative Litigation </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-10408</FONT></FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>CORPORATE GOVERNANCE </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman">In
connection with the settlement of the above-referenced action, Walgreens Boots Alliance, Inc. (the &#147;Company&#148;) shall take such actions as are necessary to implement or initiate, as appropriate, the following corporate governance reforms for
a period of no less than five years (the &#147;Implementation Period&#148;): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>I.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>OUTSIDE COUNSEL REVIEW OF DISCLOSURE-RELATED POLICIES AND PROCEDURES </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Outside counsel shall be retained to evaluate all of the Company&#146;s disclosure-related policies and
procedures. This includes any and all policies and procedures governing, among other things: </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">1.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">the Disclosure Committee; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">2.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">quarterly and annual earnings releases; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">3.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">SEC filings; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">4.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">SOX certifications; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">5.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Reg FD; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">6.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">material <FONT STYLE="white-space:nowrap">non-public</FONT> information, including internal reporting of any
material <FONT STYLE="white-space:nowrap">non-public</FONT> information among management and to the Board; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">7.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">meetings with investors and analysts; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">8.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">authorized spokespersons; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">9.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">quiet periods; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">10.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">forward-looking statements; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">11.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">press releases and other statements to the media; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">12.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">statements on the internet or social media; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="11%">&nbsp;</TD>
<TD WIDTH="5%" VALIGN="top" ALIGN="left">13.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">any review and approval of disclosures by directors. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Outside counsel&#146;s review shall, among other things, assess whether the Company&#146;s disclosure-related
policies and procedures: (i)&nbsp;are consistent with or exceed industry best standards; and (ii)&nbsp;provide for routine and timely communication between management and the Board regarding the Company&#146;s long-term financial goals, performance,
material risks, and other important issues relevant to the Company&#146;s disclosures. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Outside counsel shall be a top 20 global law firm with relevant experience in corporate governance best
practices within the industry. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">D.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Outside counsel shall have full access to all materials or personnel necessary for its evaluation.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">E.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Outside counsel shall provide a presentation of its findings and any recommendations for changes to the
Company&#146;s General Counsel and Board. Outside counsel shall be available to answer any questions regarding the Company&#146;s disclosure-related policies and procedures, and/or any recommended changes. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">F.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">In response to any recommendations made by outside counsel, the Board (after consultation with outside counsel
and the Company&#146;s General Counsel) shall exercise its good-faith business judgment and make a formal resolution on how to proceed in the best interests of the Company. <B></B> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 23 of 51 PageID #:559
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">G.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company agrees to fund this review and any changes that are recommended by outside counsel and adopted.<B>
</B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">H.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">This process will be repeated in years 1, 3, and 5 of the Implementation Period.<B> </B> </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>II.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>MANDATORY TRAINING FOR DIRECTORS AND SENIOR OFFICERS </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Outside counsel shall be retained to provide training to directors and senior officers regarding
disclosure-related laws, regulations, policies, and procedures.<B> </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B></B>B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Outside counsel shall be a top 20 global law firm with relevant experience in corporate governance best
practices within the industry. <B></B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Outside counsel shall conduct a training at a regularly scheduled board meeting regarding disclosure-related
laws, regulations, policies, and procedures.<B> </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B></B>D.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">Outside counsel shall conduct a training of senior officers who participate in the Company&#146;s disclosure
process regarding disclosure-related laws, regulations, policies, and procedures. <B></B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">E.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company agrees to fund this training.<B> </B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">F.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">This training will be repeated in years 1, 3, and 5 of the Implementation Period. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B></B>Plaintiff&#146;s filing and prosecution of this action was a factor in causing the Company to make the following
corporate governance reforms:<B> </B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>III.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>CREDIT FOR INVOLVEMENT OF ADDITIONAL <FONT STYLE="white-space:nowrap">IN-HOUSE</FONT> COUNSEL AND OUTSIDE
COUNSEL IN DISCLOSURES </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company hired an additional <FONT STYLE="white-space:nowrap">in-house</FONT> counsel within the legal
department to assist with disclosures. This <FONT STYLE="white-space:nowrap">in-house</FONT> counsel has responsibility for securities laws matters, participates in the company&#146;s disclosure process, and provides legal advice regarding
disclosures.<B> </B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company retained outside disclosure counsel. Outside disclosure counsel is a major national law firm that
participates in the company&#146;s disclosure process and provides legal advice regarding disclosures. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>IV.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>CREDIT FOR IMPROVEMENTS TO DISCLOSURE PROCEDURES </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company enhanced its SOX certification procedures.<B> </B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company centralized accountability for financial information verification in the Financial
Planning&nbsp;&amp; Analysis group during the process of compiling and vetting earnings releases. <B></B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company locked disclosures for earnings calls earlier in advance of the call, and implemented <FONT
STYLE="white-space:nowrap">pre-recording</FONT> of the scripted portion of each earnings call. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B></B>D.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company implemented a software solution to facilitate the drafting of earnings materials.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>V.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>CREDIT FOR REVISIONS TO DISCLOSURE-RELATED POLICIES </B></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">A.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company&#146;s policies were revised to expressly identify the General Counsel as responsible for
administering disclosure matters, subject to review by the Disclosure Committee. <B></B> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 24 of 51 PageID #:560
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">B.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company&#146;s policies were revised to provide further guidance on <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">one-on-one</FONT></FONT> or small group meetings with analysts and investors. <B></B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">C.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company&#146;s policies were revised to formalize the practice that, to the extent possible, the substance
of any potential analyst or investor communications is to be reviewed in advance with Investor Relations and, as necessary, the General Counsel, and that all presentations include appropriate safe harbor language. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B></B>D.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company&#146;s policies were revised to clarify that the company will not issue new earnings estimates,
reaffirm prior estimates, or revise any previously issued estimates in any <FONT STYLE="white-space:nowrap">non-public</FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">one-on-one</FONT></FONT> or small group meeting, and that
any mention of guidance in <FONT STYLE="white-space:nowrap">non-public</FONT> meetings must be limited to stating that the guidance was as of the last date given and that the company will not update or confirm guidance except in a Reg FD compliant
manner. <B></B> </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left">E.</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left">The Company&#146;s policies were revised to clarify when and how an authorized spokesperson can speak to the
investment community during the quiet period. <B></B> </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 25 of 51 PageID #:561
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>&nbsp;&nbsp;&nbsp;&nbsp; </B></P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:72pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT B </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 26 of 51 PageID #:562
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES DISTRICT COURT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>NORTHERN DISTRICT OF ILLINOIS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>EASTERN DIVISION </B></P> <P STYLE="font-size:14pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">COREY CUTLER AS PERSONAL REPRESENTATIVE OF THE ESTATE OF ANNE SHIRLEY CUTLER, Derivatively on Behalf of WALGREEN CO.,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-10408</FONT></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:13.00em; font-size:12pt; font-family:Times New Roman">Plaintiff,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Hon. Nancy L. Maldonado</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:12pt; font-family:Times New Roman">v.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">GREGORY D. WASSON, JAMES A. SKINNER, WILLIAM C. FOOTE, STEFANO PESSINA, ALAN G. MCNALLY, NANCY M. SCHLICHTING, ALEJANDRO SILVA, STEPHEN A. DAVIS, MARK P. FRISSORA, GINGER L.
GRAHAM, DAVID J. BRAILER, DOMINIC P. MURPHY, JANICE M. BABIAK, WADE D. MIQUELON, and DAVID Y. SCHWARTZ,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman"><B>EXHIBIT B</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:13.00em; font-size:12pt; font-family:Times New Roman">Defendants,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:12pt; font-family:Times New Roman">&#150; and &#150;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">WALGREEN CO., a Illinois corporation,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:13.00em; font-size:12pt; font-family:Times New Roman">Nominal Defendant.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:14pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><U>[PROPOSED] PRELIMINARY APPROVAL ORDER</U> </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 27 of 51 PageID #:563
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">This matter came before the Court for a hearing on
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2023. Plaintiff has made an unopposed motion, pursuant to Rule 23.1 of the Federal Rules of Civil Procedure, for an
order: (i)&nbsp;preliminarily approving the proposed settlement (&#147;Settlement&#148;) of shareholder derivative claims, in accordance with the Stipulation of Settlement dated March&nbsp;22, 2023 (the &#147;Stipulation&#148;); and
(ii)&nbsp;approving the form and manner of Notice of the Settlement.<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">WHEREAS, the Stipulation sets forth the terms and conditions for the Settlement, including, but not limited to a proposed
Settlement and dismissal with prejudice of the above-captioned action, titled <I>Corey Cutler as Personal Representative of the Estate of Anne Shirley Cutler v. Wasson, et al.</I>, Case No. <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">1:14-cv-10408</FONT></FONT> (the &#147;Action&#148;); </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">WHEREAS, the Court having: (i)&nbsp;read
and considered Plaintiff&#146;s Unopposed Motion for Preliminary Approval of Shareholder Derivative Settlement together with the accompanying Memorandum of Points and Authorities; (ii)&nbsp;read and considered the Stipulation, as well as all the
exhibits attached thereto; and (iii)&nbsp;heard and considered arguments by counsel for the Parties in favor of preliminary approval of the Settlement; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">WHEREAS, the Court finds, upon a preliminary evaluation, that the proposed Settlement falls within the range of possible
approval criteria, as it confers a benefit on Walgreen Co. (&#147;Walgreens&#148;) and appears to be the product of serious, informed, <FONT STYLE="white-space:nowrap">non-collusive</FONT> negotiations overseen by an experienced mediator; and </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">WHEREAS, the Court also finds, upon a preliminary evaluation, that Walgreens shareholders should be apprised of the Settlement
through the proposed form of Notice, allowed to file objections, if any, thereto, and appear at the Settlement Hearing. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:24%">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman"><SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> Except as otherwise expressly provided below or as the context otherwise requires, all capitalized terms contained herein shall have the same meanings and/or definitions as set forth in the
Stipulation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 1 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 28 of 51 PageID #:564
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">NOW, THEREFORE, IT IS HEREBY ORDERED, ADJUDGED, AND DECREED AS FOLLOWS: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.&nbsp;&nbsp;&nbsp;&nbsp; This Court, for purposes of this Preliminary Approval Order, adopts the definitions set forth in the
Stipulation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">2.&nbsp;&nbsp;&nbsp;&nbsp; This Court preliminarily approves, subject to further consideration at the
Settlement Hearing described below, the Settlement as set forth in the Stipulation as being fair, reasonable, and adequate. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">3.&nbsp;&nbsp;&nbsp;&nbsp; A hearing shall be held on
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2023 at <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> <U>&nbsp;&nbsp;</U>.m., before
the Honorable Nancy L. Maldonado at the U.S. District Court for the Northern District of Illinois, Everett McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Courtroom 1925, Chicago, Illinois 60604 (the &#147;Settlement
Hearing&#148;), at which the Court will determine: (i)&nbsp;whether the terms of the Settlement should be approved as fair, reasonable, and adequate; (ii)&nbsp;whether the Notice fully satisfied the requirements of Rule 23.1 of the Federal Rules of
Civil Procedure and the requirements of due process; (iii)&nbsp;whether all Released Claims against the Released Persons should be fully and finally released; (iv)&nbsp;whether the <FONT STYLE="white-space:nowrap">agreed-to</FONT> Fee and Expense
Amount should be approved; and (v)&nbsp;such other matters as the Court may deem appropriate. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">4.&nbsp;&nbsp;&nbsp;&nbsp;
The Court finds that the form, substance, and dissemination of information regarding the proposed Settlement in the manner set out in this Preliminary Approval Order constitutes the best notice practicable under the circumstances and complies fully
with Rule 23.1 of the Federal Rules of Civil Procedure and due process. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">5.&nbsp;&nbsp;&nbsp;&nbsp; Within fifteen
(15)&nbsp;business days after the entry of this Preliminary Approval Order, Walgreens shall file the Stipulation and the Notice with the SEC on Form <FONT STYLE="white-space:nowrap">8-K,</FONT> and Walgreens shall post a link to the Stipulation and
the Notice on the &#147;Investor Relations&#148; page of Walgreens&#146; website, the address of which shall be contained in the Notice. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 29 of 51 PageID #:565
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">6.&nbsp;&nbsp;&nbsp;&nbsp; All costs incurred in the filing and posting of the Notice shall be paid by Walgreens, and Walgreens
shall undertake all administrative responsibility for the filing and posting of the Notice. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.&nbsp;&nbsp;&nbsp;&nbsp; At
least thirty (30)&nbsp;calendar days prior to the Settlement Hearing, Defendants&#146; Counsel shall file with the Court an appropriate declaration with respect to filing and posting the Notice as provided for in paragraph 5 of this Preliminary
Approval Order. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">8.&nbsp;&nbsp;&nbsp;&nbsp; Pending final determination of whether the Settlement should be approved, no
Walgreens shareholders shall commence or prosecute against any of the Released Persons any action or proceeding in any court or tribunal asserting any of the Released Claims. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">9.&nbsp;&nbsp;&nbsp;&nbsp; At least <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;calendar days prior to the
Settlement Hearing, Plaintiff&#146;s Counsel shall file with the Court and serve on Defendants&#146; Counsel all papers in support of the Settlement and the Fee and Expense Amount. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">10.&nbsp;&nbsp;&nbsp;&nbsp; Any shareholders owning Walgreens common stock as of March&nbsp;22, 2023, that continue to hold
Walgreens common stock through the date of the Settlement Hearing may appear and show cause, at their own expense, individually or through counsel, if they have any reason why any term of the Settlement embodied in the Stipulation, including the Fee
and Expense Amount, should not be approved as fair, reasonable, and adequate, or why a judgment should or should not be entered thereon. However, no Walgreens shareholder shall be heard or entitled to contest the approval of the proposed Settlement,
or, if approved, the Order and Final Judgment to be entered thereon, unless that Walgreens shareholder has caused to be filed, and served on counsel, a written notice of objection that includes the following: (i)&nbsp;the Person&#146;s name, legal
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 30 of 51 PageID #:566
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">address, and telephone number; (ii)&nbsp;the case name and number (<I>Corey Cutler as Personal Representative of the Estate of Anne Shirley
Cutler v. Wasson, et al.</I>, Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-10408);</FONT></FONT> (iii) competent evidence that such Person held shares of Walgreens common stock as of the date of the Stipulation
and continues to hold such stock as of the date the objection is made; (iv)&nbsp;the date(s) that such Person acquired Walgreens shares; (v)&nbsp;a statement of each objection being made; (vi)&nbsp;notice of whether such Person intends to appear at
the Settlement Hearing, and whether they are represented by counsel and if so, contact information for counsel; and (vii)&nbsp;copies of any papers such Person intends to submit to the Court, along with the names of any witness(es) they intend to
call to testify at the Settlement Hearing and the subject(s) of their testimony. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">11.&nbsp;&nbsp;&nbsp;&nbsp; At least
fourteen (14)&nbsp;calendar days prior to the Settlement Hearing set for <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2023, any such Person
objecting as set forth in paragraph 10 must: (i)&nbsp;file the written objection(s) and corresponding materials with the Clerk of the Court, U.S. District Court for the Northern District of Illinois, Everett McKinley Dirksen United States
Courthouse, 219 South Dearborn Street, Courtroom 1925, Chicago, Illinois; and (ii)&nbsp;serve copies of the same materials by hand delivery, overnight mail, or the court&#146;s electronic filing and service system so they are received no later than
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> <U>&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2023 by the following counsel for Plaintiff and Defendants: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="5%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="46%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>Counsel for Plaintiff:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I>Counsel for Defendants:</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ROBBINS LLP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">SIDLEY AUSTIN LLP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ASHLEY R. RIFKIN</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">JOHN M. SKAKUN III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5060 Shoreham Place, Suite 300</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">One South Dearborn Street</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">San Diego, CA 92122</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chicago, IL 60603</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Telephone: (619) <FONT STYLE="white-space:nowrap">525-3990</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Telephone: (312) <FONT STYLE="white-space:nowrap">853-7000</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Facsimile: (619) <FONT STYLE="white-space:nowrap">525-3991</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Facsimile: (312) <FONT STYLE="white-space:nowrap">853-7036</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">12.&nbsp;&nbsp;&nbsp;&nbsp; Only shareholders who have filed with the Court and sent to the
Parties&#146; counsel valid and timely written notices of objection will be entitled to be heard at the Settlement Hearing unless the Court orders otherwise. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 31 of 51 PageID #:567
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">13.&nbsp;&nbsp;&nbsp;&nbsp; Any Person or entity who fails to appear or object in the manner provided herein shall be deemed to
have waived such objection and shall forever be foreclosed from making any objection to the fairness, reasonableness, or adequacy of the Settlement, unless otherwise ordered by the Court, and shall otherwise be bound by the Order and Final Judgment
to be entered and the releases to be given. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">14.&nbsp;&nbsp;&nbsp;&nbsp; Any attorney hired by a shareholder for the
purpose of objecting to the Settlement must file a notice of appearance with the Clerk of the Court no later than <FONT STYLE="white-space:nowrap">twenty-one</FONT> (21)&nbsp;calendar days before the Settlement Hearing. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">15.&nbsp;&nbsp;&nbsp;&nbsp; Any replies to any objections shall be filed with the Court and served at least seven
(7)&nbsp;calendar days prior to the Settlement Hearing. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">16.&nbsp;&nbsp;&nbsp;&nbsp; All proceedings in the Action are
stayed until further order of the Court, except as may be necessary to implement the Settlement or comply with the terms of the Stipulation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">17.&nbsp;&nbsp;&nbsp;&nbsp; This Court may, for good cause, extend any of the deadlines set forth in this Preliminary Approval
Order without further notice to Walgreens shareholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">18.&nbsp;&nbsp;&nbsp;&nbsp; Neither the Stipulation nor the
Settlement, nor any act performed or document executed pursuant to or in furtherance of the Stipulation or the Settlement: (i)&nbsp;is or may be deemed to be or may be offered, attempted to be offered or used in any way by the Parties or any other
Person as a presumption, a concession or an admission of, or evidence of, any fault, wrongdoing or liability of the Parties or Released Persons, or of the validity of any Released Claims; or (ii)&nbsp;is intended by the Parties to be offered or
received as evidence or used by any other person in any other actions or proceedings, whether civil, criminal, or administrative, other than to enforce the terms therein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 32 of 51 PageID #:568
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">19.&nbsp;&nbsp;&nbsp;&nbsp; In the event that the Settlement does not become effective in accordance with the terms of the
Stipulation or the Effective Date does not occur, then this Order shall be rendered null and void to the extent provided by and in accordance with the Stipulation and shall be vacated and, in such event, all orders entered and releases provided in
connection herewith shall be null and void to the extent provided by and in accordance with the Stipulation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">20.&nbsp;&nbsp;&nbsp;&nbsp; The Court retains jurisdiction to consider all further applications arising out of or connected
with the Settlement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>IT IS SO ORDERED. </B></P> <P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="25%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="25%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">DATED:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;HONORABLE NANCY L. MALDONADO</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">&nbsp;U.S. DISTRICT JUDGE</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">1613291 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 33 of 51 PageID #:569
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:48pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:72pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT C </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 34 of 51 PageID #:570
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES DISTRICT COURT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>NORTHERN DISTRICT OF ILLINOIS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>EASTERN DIVISION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">COREY CUTLER AS PERSONAL REPRESENTATIVE OF THE ESTATE OF ANNE SHIRLEY CUTLER, Derivatively on Behalf of WALGREEN CO.,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-10408</FONT></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:12.00em; font-size:12pt; font-family:Times New Roman">Plaintiff,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Hon. Nancy L. Maldonado</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:12pt; font-family:Times New Roman">v.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">GREGORY D. WASSON, JAMES A. SKINNER, WILLIAM C. FOOTE, STEFANO PESSINA, ALAN G. MCNALLY, NANCY M. SCHLICHTING, ALEJANDRO SILVA, STEPHEN A. DAVIS, MARK P. FRISSORA, GINGER
L. GRAHAM, DAVID J. BRAILER, DOMINIC P. MURPHY, JANICE M. BABIAK, WADE D. MIQUELON, and DAVID Y. SCHWARTZ,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><B>EXHIBIT C</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:12.00em; font-size:12pt; font-family:Times New Roman">Defendants,</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:12pt; font-family:Times New Roman">&#150; and &#150;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">WALGREEN CO., a Illinois corporation,</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:12.00em; font-size:12pt; font-family:Times New Roman">Nominal Defendant.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><U>SHAREHOLDER DERIVATIVE ACTION</U> </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 35 of 51 PageID #:571
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>TO:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>ALL OWNERS OF THE COMMON STOCK OF WALGREENS (THE &#147;COMPANY&#148;) CURRENTLY AND AS OF MARCH&nbsp;22,
2023 (&#147;CURRENT WALGREENS SHAREHOLDERS&#148;): </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><B>THIS NOTICE RELATES TO THE PENDENCY AND PROPOSED SETTLEMENT OF
SHAREHOLDER DERIVATIVE LITIGATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. IF YOU ARE A WALGREENS SHAREHOLDER, THIS NOTICE CONTAINS IMPORTANT INFORMATION ABOUT YOUR RIGHTS. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><B>THIS ACTION IS NOT A &#147;CLASS ACTION.&#148; THUS, THERE IS NO COMMON FUND UPON WHICH YOU CAN MAKE A CLAIM FOR A MONETARY PAYMENT.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>YOU ARE HEREBY NOTIFIED</B>, pursuant to an Order of the U.S. District Court for the Northern District of Illinois
(the &#147;Court&#148;), that a proposed settlement has been reached by the parties to the following shareholder derivative action brought on behalf and for the benefit of Walgreens: <I>Corey Cutler as Personal Representative of the Estate of Anne
Shirley Cutler v. </I><I>Wasson, et al.</I>, Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-1040</FONT></FONT> (the &#147;Action&#148;).<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">As explained below, a hearing will be held on
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2023 at <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
<U>&nbsp;&nbsp;</U>.m., before the Honorable Nancy L. Maldonado at the U.S. District Court for the Northern District of Illinois, Everett McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Courtroom 1925, Chicago, Illinois 60604
(the &#147;Settlement Hearing&#148;), at which the Court will determine: (i)&nbsp;whether the terms of the Settlement are fair, reasonable, and adequate and should be approved; (ii)&nbsp;whether a final order and judgment should be entered,
dismissing the Action with prejudice and extinguishing and fully and finally releasing all of the Released Claims against the Released Persons; (iii)&nbsp;whether the Court should award the requested attorneys&#146; fees and reimbursement of
expenses for Plaintiff&#146;s Counsel and service award to the Plaintiff; and (iv)&nbsp;such other actions as may be necessary or proper under the circumstances. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:26%">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> All capitalized terms herein have the same meanings as set forth Parties&#146; Stipulation of Settlement dated March&nbsp;22, 2023 (the &#147;Stipulation&#148;), which is available for viewing on the
website of Walgreens at www. investor.walgreensbootsalliance.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 1 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 36 of 51 PageID #:572
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The terms of the Settlement are set forth in the Stipulation and summarized in this Notice. The Settlement provides for
corporate governance reforms relating to Walgreens&#146; disclosure-related policies and procedures. If approved by the Court, the Settlement will fully resolve the Action, including the dismissal of the Action with prejudice. For a more detailed
statement of the matters involved in the Action, the Settlement, and the terms discussed in this Notice, the Stipulation may be inspected at the Clerk of Court&#146;s office, U.S. District Court for the Northern District of Illinois, Everett
McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Chicago, Illinois 60604. The Stipulation is also available for viewing on the website of Walgreens at www. investor.walgreensbootsalliance.com. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">This Notice is not intended to be an expression of any opinion by the Court with respect to the merits of the claims made in
the Action, but is merely to advise you of the pendency and settlement of the Action. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>THERE IS NO CLAIMS PROCEDURE.</B>
This case was brought to protect the interests of Walgreens. The Settlement will result in changes to the Company&#146;s corporate governance, not in payment to individuals, and accordingly, there will be no claims procedure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 37 of 51 PageID #:573
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>I.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>BACKGROUND OF THE ACTION </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Proceedings in this Action </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">On December&nbsp;29, 2014, Anne Cutler<SUP STYLE="font-size:75%; vertical-align:top">2</SUP> filed a shareholder derivative
complaint (&#147;Complaint&#148;) derivatively on behalf of Walgreens against certain of the Company&#146;s current and former officers and directors for alleged breaches of fiduciary duty, waste of corporate assets, and unjust enrichment in
connection with their alleged failure to disclose material information concerning the Company&#146;s future business prospects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Defendants filed motions to dismiss the Complaint on April&nbsp;10, 2015, and a motion for a protective order staying discovery
on April&nbsp;13, 2015. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The Parties then engaged in discussions regarding scheduling and the coordination of this
derivative action with the related Securities Action, titled <I>Washtenaw County Employees&#146; Retirement System v. Walgreen Co.</I>, Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:15-cv-03187,</FONT></FONT> which was
pending before the Court. On May&nbsp;18, 2015, the Court entered an order approving the Parties&#146; stipulation to stay this shareholder derivative action pending resolution of the motion to dismiss the Securities Action. Thereafter, on
November&nbsp;3, 2016, the Court entered an order approving the Parties&#146; stipulation to stay this action pending final resolution of the Securities Action. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Settlement Efforts </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Shortly after the Court granted in part the defendants&#146; motion for summary judgment in the Securities Action, the Parties
commenced negotiations to settle this Action. The Parties engaged in significant <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiations regarding certain corporate governance reforms with the </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:26%">&nbsp;</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><SUP STYLE="font-size:75%; vertical-align:top">2</SUP> Anne Cutler died on November&nbsp;4, 2018. On May&nbsp;31, 2019, the Court granted Plaintiff&#146;s
motion to substitute Ms.&nbsp;Cutler&#146;s son, Corey Cutler, as Personal Representative of the Estate of Anne Shirley Cutler. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 38 of 51 PageID #:574
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">supervision and assistance of highly-experienced and well-respected mediators Hon. Layn R. Phillips (Ret.) and Niki Mendoza from Phillips ADR.
After several months, during which the Parties exchanged proposals and counter-proposals and Plaintiff&#146;s Counsel reviewed the Company&#146;s pertinent <FONT STYLE="white-space:nowrap">non-public</FONT> disclosure policies, the Parties reached
an agreement on the Reforms (defined below) to be implemented as part of the proposed Settlement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Thereafter, the Parties
negotiated the formal operative terms of the Settlement as set forth in the Stipulation and commenced <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiations regarding an appropriate amount of attorneys&#146; fees and expenses to be
paid to Plaintiff&#146;s Counsel in recognition of the benefits conferred by the Settlement. The fee negotiations were facilitated and supervised by mediator Niki Mendoza and culminated in the Parties&#146; agreement to a Fee and Expense Amount of
$950,000, subject to Court approval. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>II.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>PLAINTIFF&#146;S CLAIMS AND THE BENEFITS OF SETTLEMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Plaintiff believes that the Action has substantial merit, and Plaintiff&#146;s entry into this Stipulation and Settlement is
not intended to be and shall not be construed as an admission or concession concerning the relative strength or merit of the claims alleged in the Action. However, Plaintiff and Plaintiff&#146;s Counsel recognize and acknowledge the significant
risk, expense, and length of continued proceedings necessary to prosecute the Action against the Individual Defendants through trial and possible appeals. Plaintiff&#146;s Counsel have also taken into account the uncertain outcome and the risk of
any litigation, especially in complex cases such as the Action, as well as the difficulties and delays inherent in such litigation. Plaintiff&#146;s Counsel are also mindful of the inherent problems of establishing standing to pursue this derivative
action, and the possible defenses to the claims alleged. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Plaintiff&#146;s Counsel have conducted extensive investigation
and analysis, including, <I>inter alia</I>: (i)&nbsp;reviewing Walgreens&#146;<B> </B>press releases, public statements, U.S. Securities and Exchange </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 39 of 51 PageID #:575
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Commission (&#147;SEC&#148;) filings, and securities analysts&#146; reports and advisories about the Company; (ii)&nbsp;reviewing related media
reports about the Company; (iii)&nbsp;reviewing <FONT STYLE="white-space:nowrap">non-public</FONT> documents produced in connection with the related Securities Action; (iv)&nbsp;researching applicable law with respect to the claims alleged in the
Action and potential defenses thereto; (iv)&nbsp;reviewing and analyzing the allegations and pleadings filed in the related Securities Action; (v)&nbsp;preparing and filing a derivative complaint; (vi)&nbsp;conducting damages analyses; and
(vii)&nbsp;negotiating this Settlement with Defendants, including researching corporate governance best practices and negotiating the Reforms.&nbsp;&nbsp;&nbsp;&nbsp; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Based on Plaintiff&#146;s Counsel&#146;s thorough review and analysis of the relevant facts, allegations, defenses, and
controlling legal principles, Plaintiff&#146;s Counsel believe that the Settlement set forth in the Stipulation is fair, reasonable, and adequate, and confers substantial benefits upon Walgreens. Based upon Plaintiff&#146;s Counsel&#146;s
evaluation, Plaintiff has determined that it believes the Settlement is in the best interests of Walgreens<B> </B>and has agreed to settle the Action upon the terms and subject to the conditions set forth in the Stipulation. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>III.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>DEFENDANTS&#146; DENIALS OF WRONGDOING AND LIABILITY </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Defendants have denied and continue to deny each and all of the claims alleged by Plaintiff in the Action, including that there
was any wrongdoing, any liability, or any harm to Walgreens. In particular, the Individual Defendants have expressly denied and continue to deny all charges of wrongdoing or liability against them, and any harm to Walgreens, arising out of any of
the conduct, statements, acts, or omissions alleged, or that could have been alleged, in the Action. Nonetheless, Defendants have concluded that further litigation would be protracted, expensive, and distracting, and have also taken into account the
uncertainty and risks inherent in any litigation, especially in complex cases like the Action. Defendants have, therefore, determined that the Settlement confers a substantial benefit upon Walgreens and its shareholders, and the Settlement, and each
of its terms, is in all respects fair, reasonable, and in the best interests of Walgreens and its shareholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 40 of 51 PageID #:576
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Neither the Stipulation, nor any of its terms or provisions, nor entry of the Judgment, nor any document or exhibit referred or
attached to the Stipulation, nor any action taken to carry out the Stipulation, is, may be construed as, or may be used as evidence of the validity of any of the Released Claims or an admission by or against any of the Defendants of any fault,
wrongdoing, or concession of liability whatsoever. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>IV.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>TERMS OF THE SETTLEMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The terms and conditions of the proposed Settlement are set forth in the Stipulation, which has been filed with the Court and
is available for viewing on Walgreens&#146; website at www.investor.walgreensbootsalliance.com. The following is only a summary of its terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the Settlement, and in consideration for the Settlement and release of all the Released Claims, Walgreens has
agreed to implement and maintain the corporate governance reforms set forth in Exhibit A to the Stipulation (&#147;Reforms&#148;) for a period of no less than five (5)&nbsp;years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Walgreens<B> </B>acknowledges that, unless otherwise stated in Exhibit A, the prosecution and settlement of the Action was the
sole factor<B> </B>in the agreement to adopt and/or implement the Reforms. The Defendants further acknowledge and agree that the Settlement confers a substantial benefit upon Walgreens and its shareholders, and the Settlement, and each of its terms,
is in all respects fair, reasonable, and in the best interests of Walgreens and its shareholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">For a complete
description of all of the Reforms, please see Exhibit A to the Stipulation, which is available for viewing on Walgreens&#146; website at www.investor.walgreensbootsalliance.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 41 of 51 PageID #:577
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>V.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>DISMISSAL AND RELEASES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The Settlement is conditioned upon the occurrence of certain events, which include, among other things, entry of an order by
the Court approving the Settlement and dismissing the Action with prejudice. The Settlement will not become effective until such an order has been entered and become final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> (the
&#147;Effective Date&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Upon the Effective Date, the Releasing Parties shall be deemed to have fully, finally, and
forever released, relinquished, and discharged the Released Claims (including Unknown Claims) against the Released Persons, and any and all claims arising out of, relating to, or in connection with the defense, settlement, or resolution of the
Action against the Released Persons. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">In addition, upon the Effective Date, each of the Defendants shall be deemed to have
fully, finally, and forever released, relinquished, and discharged Plaintiff and Plaintiff&#146;s Counsel from all claims (including Unknown Claims), arising out of, relating to, or in connection with the institution, prosecution, assertion,
settlement, or resolution of the Action or the Released Claims. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Nothing in these releases, however, shall in any way
impair or restrict the rights of any Party to enforce the terms of the Stipulation. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>VI.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>PLAINTIFF&#146;S ATTORNEYS&#146; FEES AND EXPENSES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">After negotiating the substantive terms of the Settlement, including the Reforms, the Parties commenced negotiations regarding
the attorneys&#146; fees and expenses to be paid to Plaintiff&#146;s Counsel. These negotiations, which were overseen by mediators Hon. Layn R. Phillips (Ret.) and Niki Mendoza from Phillips ADR, concluded with Walgreens and/or the Defendants&#146;
insurers agreement to pay Plaintiff&#146;s Counsel&#146;s attorneys&#146; fees and expenses in the total amount of $950,000 (the &#147;Fee and Expense Amount&#148;), subject to Court approval. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Plaintiff&#146;s Counsel may also apply to the Court for a service award of up to $2,500 for Plaintiff, only to be paid upon
Court approval, and to be paid from the Fee and Expense Amount </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 7 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 42 of 51 PageID #:578
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">in recognition of Plaintiff&#146;s participation and effort in the prosecution of the Action. Neither Walgreens nor any of the Individual
Defendants shall be liable for any portion of any service award. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">To date, Plaintiff&#146;s Counsel have neither received
any payment for their services in conducting the Action, nor been reimbursed for their <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>VII.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>THE SETTLEMENT HEARING </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The Settlement Hearing will be held before the Honorable Nancy L. Maldonado at the U.S. District Court for the Northern
District of Illinois, Everett McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Courtroom 1925, Chicago, Illinois 60604, at which the Court will determine: (i)&nbsp;whether the terms of the Stipulation should be approved as fair,
reasonable, and adequate; (ii)&nbsp;whether the Notice fully satisfied the requirements of Rule 23.1 of the Federal Rules of Civil Procedure and the requirements of due process; (iii)&nbsp;whether all Released Claims against the Released Persons
should be fully and finally released; (iv)&nbsp;whether the <FONT STYLE="white-space:nowrap">agreed-to</FONT> Fee and Expense Amount should be approved; and (v)&nbsp;such other matters as the Court may deem appropriate. The Settlement Hearing may be
continued by the Court at the Settlement Hearing, or at any adjourned session thereof, without further notice. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>VIII.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>THE RIGHT TO ATTEND AND/OR OBJECT AT THE SETTLEMENT HEARING </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">You have the right, but are not required, to appear in person or through counsel at the Settlement Hearing to object to the
terms of the proposed Settlement or otherwise present evidence or argument that may be proper and relevant. If you want to be heard at the Settlement Hearing, then you must first comply with the procedures for objecting, which are set forth below.
The Court has the right to change the hearing date, time, or platform (in person, by video or telephone conference) without further notice. Thus, if you are planning to participate in the Settlement Hearing, you should confirm the date, time and
platform before going to the Court, and you may consult the Court&#146;s calendar for any change in date or time of, or platform used for, the Settlement Hearing. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 8 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 43 of 51 PageID #:579
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Unless otherwise ordered by the Court, you shall be heard or entitled to contest the approval of the proposed Settlement, or,
if approved, the Order and Final Judgment to be entered thereon, or the amount of attorneys&#146; fees and reimbursement of expenses to Plaintiff&#146;s Counsel, only if you have, <B><I>at least fourteen
(14)</I></B><B><I></I></B><B><I>&nbsp;calendar days prior to the Settlement Hearing</I></B>, filed with the Court a written notice of objection containing the following information: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1. &nbsp;&nbsp;&nbsp;&nbsp;Your name, legal address, and telephone number; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">2. &nbsp;&nbsp;&nbsp;&nbsp;The case name and number (<I>Corey Cutler as Personal Representative of the Estate of Anne Shirley
Cutler v. Wasson, et al.</I>, Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-10408);</FONT></FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">3. &nbsp;&nbsp;&nbsp;&nbsp;Proof of being a Walgreens shareholder currently and as of March&nbsp;22, 2023; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">4. &nbsp;&nbsp;&nbsp;&nbsp;The date(s) you acquired your Walgreens shares; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">5. &nbsp;&nbsp;&nbsp;&nbsp;A statement of each of each objection being made; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">6. &nbsp;&nbsp;&nbsp;&nbsp;Notice of whether you intend to appear at the Settlement Hearing, and whether you are represented by
counsel and if so, contact information for your counsel (you are not required to appear); and </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.
&nbsp;&nbsp;&nbsp;&nbsp;Copies of any papers you intend to submit to the Court, along with the names of any witness(es) you intend to call to testify at the Settlement Hearing and the subject(s) of their testimony. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">If you wish to object to the proposed Settlement, you must file the written objection described above with the Court on or
before <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2023. All written objections and supporting papers must be filed with the Clerk of the Court, U.S. District Court for the Northern District of Illinois, Everett
McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Chicago, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 9 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 44 of 51 PageID #:580
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Illinois 60604. You must also serve copies of the same materials by hand delivery, overnight mail, or the court&#146;s electronic filing and
service system so they are received no later than <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> <U>&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2023 by the following counsel for Plaintiff and Defendants: </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="94%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="35%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="64%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"><I>Counsel for Plaintiff:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><I>Counsel for Defendants:</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">ROBBINS LLP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>SIDLEY AUSTIN LLP</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">ASHLEY R. RIFKIN*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>JOHN M. SKAKUN III</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">5060 Shoreham Place, Suite 300</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>One South Dearborn Street</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">San Diego, CA 92122</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Chicago, IL 60603</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">Telephone: (619) <FONT STYLE="white-space:nowrap">525-3990</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Telephone: (312) <FONT STYLE="white-space:nowrap">853-7000</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">Facsimile: (619) <FONT STYLE="white-space:nowrap">525-3991</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Facsimile: (312) <FONT STYLE="white-space:nowrap">853-7036</FONT></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">YOUR WRITTEN OBJECTIONS MUST BE ON FILE WITH THE CLERK OF THE COURT AND RECEIVED BY COUNSEL NO
LATER THAN <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2023. Only shareholders who have filed and delivered valid and timely written notices of objection will be entitled to be heard at the Settlement Hearing
unless the Court orders otherwise. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Unless otherwise ordered by the Court, any shareholder who does not make his, her, or
its objection in the manner provided herein shall be deemed to have waived such objection and shall forever be barred and foreclosed from making any objection to the fairness, reasonableness, or adequacy of the Settlement, unless otherwise ordered
by the Court, and shall otherwise be bound by the Final Order and Judgment to be entered and the releases to be given. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>IX.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>EXAMINATION OF PAPERS AND INQUIRIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">There is additional information concerning the Settlement available in the Stipulation, which is available for viewing on
Walgreens&#146; website at www.investor.walgreensbootsalliance.com. You may also inspect the Stipulation during business hours at the office of the Clerk of the Court, U.S. District Court for the Northern District of Illinois, Everett McKinley
Dirksen United States Courthouse, 219 South Dearborn Street, Courtroom 1925, Chicago, Illinois 60604. Or you can call Robbins LLP, 5060 Shoreham Place, Suite 300, San Diego, California 92122, telephone: (619)
<FONT STYLE="white-space:nowrap">525-3990,</FONT> for additional information concerning the Settlement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 10 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 45 of 51 PageID #:581
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PLEASE DO NOT CONTACT THE COURT OR WALGREENS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REGARDING THIS NOTICE. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">DATED:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">&nbsp;BY ORDER OF THE UNITED STATES DISTRICT</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">&nbsp;COURT FOR THE NORTHERN DISTRICT OF ILLINOIS</P></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">1613292 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 11 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 46 of 51 PageID #:582
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="justify"> </P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:120pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:36pt; margin-bottom:0pt; font-size:72pt; font-family:Times New Roman" ALIGN="center"><B>EXHIBIT D </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 47 of 51 PageID #:583
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES DISTRICT COURT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>NORTHERN DISTRICT OF ILLINOIS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>EASTERN DIVISION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">COREY CUTLER AS PERSONAL</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">REPRESENTATIVE OF THE ESTATE OF</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">ANNE SHIRLEY CUTLER, Derivatively on</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">Behalf of WALGREEN CO.,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-10408</FONT></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:10.00em; font-size:12pt; font-family:Times New Roman">Plaintiff,</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Hon. Nancy L. Maldonado</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; font-size:12pt; font-family:Times New Roman">v.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">GREGORY D. WASSON, JAMES A. SKINNER, WILLIAM C. FOOTE, STEFANO PESSINA, ALAN G. MCNALLY, NANCY M. SCHLICHTING, ALEJANDRO SILVA, STEPHEN A. DAVIS, MARK P. FRISSORA, GINGER L.
GRAHAM, DAVID J. BRAILER, DOMINIC P. MURPHY, JANICE M. BABIAK, WADE D. MIQUELON, and DAVID Y. SCHWARTZ,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman"><B>EXHIBIT D</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:10.00em; font-size:12pt; font-family:Times New Roman">Defendants,</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; font-size:12pt; font-family:Times New Roman">&#150; and &#150;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">WALGREEN CO., a Illinois corporation,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:10.00em; font-size:12pt; font-family:Times New Roman">Nominal Defendant.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><U>[PROPOSED] ORDER AND FINAL JUDGMENT </U></B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 48 of 51 PageID #:584
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">This matter came before the Court for hearing on
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>, 2023, to consider approval of the proposed settlement (&#147;Settlement&#148;) set forth in the Stipulation of Settlement dated March&nbsp;22, 2023, and the exhibits
thereto (the &#147;Stipulation&#148;). The Court has reviewed and considered all documents, evidence, objections (if any), and arguments presented in support of or against the Settlement. Good cause appearing therefore, the Court enters this
Judgment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">IT IS HEREBY ORDERED, ADJUDGED, AND DECREED that: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1. &nbsp;&nbsp;&nbsp;&nbsp;This [Proposed] Order and Final Judgment (&#147;Judgment&#148;) incorporates herein the Stipulation,
including all exhibits thereto. Unless otherwise defined herein, all capitalized terms used herein shall have the meanings given in the Stipulation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">2. &nbsp;&nbsp;&nbsp;&nbsp;This Court has jurisdiction over the subject matter of the above-captioned Action, including all
matters necessary to effectuate the Settlement, and the Parties have consented to the jurisdiction of the Court for purposes of implementing and enforcing the Settlement embodied in the Stipulation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">3. &nbsp;&nbsp;&nbsp;&nbsp;The Court finds that the Notice provided to Walgreens shareholders constituted the best notice
practicable under the circumstances. Accordingly, the Notice fully satisfied the requirements of Rule 23.1 of the Federal Rules of Civil Procedure and the requirements of due process. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">4. &nbsp;&nbsp;&nbsp;&nbsp;The Court finds that the Settlement as set forth in the Stipulation is fair, reasonable, adequate,
and in the best interests of Walgreens and Current Walgreens Shareholders. The Court hereby finally approves the Settlement in all respects and orders the Parties to perform its terms to the extent the Parties have not already done so. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 1 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 49 of 51 PageID #:585
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">5. &nbsp;&nbsp;&nbsp;&nbsp;The above-captioned Action and all claims contained therein, as well as all of the Released Claims
(including Unknown Claims), are dismissed on the merits and with prejudice. The Parties are to bear their own costs, except as otherwise provided in the Stipulation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">6. &nbsp;&nbsp;&nbsp;&nbsp;Upon the Effective Date, the Releasing Parties shall be deemed to have fully, finally, and forever
released, relinquished, and discharged the Released Claims (including Unknown Claims) against the Released Persons, and any and all claims arising out of, relating to, or in connection with the defense, settlement, or resolution of the Action
against the Released Persons. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7. &nbsp;&nbsp;&nbsp;&nbsp;Upon the Effective Date, each of the Defendants shall be deemed
to have fully, finally, and forever released, relinquished, and discharged Plaintiff and Plaintiff&#146;s Counsel from all claims (including Unknown Claims), arising out of, relating to, or in connection with the institution, prosecution, assertion,
settlement, or resolution of the Action or the Released Claims. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">8. &nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding paragraphs 6
and 7 above, nothing in the Stipulation or this Judgment shall provide a release of any claims to enforce the Stipulation, the Settlement, or this Judgment or bar any action by any Party to enforce the terms of the Stipulation, the Settlement, or
this Judgment. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">9. &nbsp;&nbsp;&nbsp;&nbsp;During the course of the Action, all parties and their respective counsel at all
times complied with the requirements of Rule 11 of the Federal Rules of Civil Procedure, and all other similar laws or statutes. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">10. &nbsp;&nbsp;&nbsp;&nbsp;Neither the Stipulation nor the Settlement, nor any act performed or document executed pursuant to
or in furtherance of the Stipulation or the Settlement: (a)&nbsp;is or may be deemed to be or may be offered, attempted to be offered, or used in any way by the Parties or any other Person as a presumption, a concession, or an admission of, or
evidence of, any fault, wrongdoing, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 50 of 51 PageID #:586
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">or liability of the Parties or Released Persons, or of the validity of any Released Claims; or (b)&nbsp;is intended by the Parties to be
offered or received as evidence or used by any other person in any other actions or proceedings, whether civil, criminal, or administrative, other than to enforce the terms therein. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">11. &nbsp;&nbsp;&nbsp;&nbsp;The Released Persons may file the Stipulation and/or the Judgment, and file or reference acts
performed or documents executed pursuant to or in furtherance of the Stipulation and/or the Judgment: (i)&nbsp;in any action that may be brought against them in order to support a defense or counterclaim based on principles of <I>res judicata</I>,
collateral estoppel, full faith and credit, release, good faith settlement, judgment bar or reduction, or any other theory of claim preclusion or issue preclusion or similar defense or counterclaim; (ii)&nbsp;in furtherance of the Settlement
contemplated in the Stipulation; and (iii)&nbsp;in any action to enforce the Settlement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">12. &nbsp;&nbsp;&nbsp;&nbsp;The
Court hereby approves the sum of $950,000 for the payment of Plaintiff&#146;s Counsel&#146;s attorneys&#146; fees and expenses in the Action (&#147;Fee and Expense Amount&#148;), and finds that the Fee and Expense Amount is fair and reasonable. No
other fees, costs, or expenses may be awarded to Plaintiff&#146;s Counsel in connection with the Settlement. The Fee and Expense Amount shall be distributed in accordance with the terms of the Stipulation. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">13. &nbsp;&nbsp;&nbsp;&nbsp;The Court hereby approves the service award of $2,500 for the Plaintiff to be paid from
Plaintiff&#146;s Counsel&#146;s Fee and Expense Amount in recognition of Plaintiff&#146;s participation and effort in the prosecution of the Action. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">14. &nbsp;&nbsp;&nbsp;&nbsp;Without affecting the finality of this Judgment in any way, this Court hereby retains continuing
jurisdiction with respect to implementation and enforcement of the terms of the Stipulation. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">15.
&nbsp;&nbsp;&nbsp;&nbsp;This Final Order and Judgment is a final judgment, and the Court finds that no just </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff">Case: 1:14-cv-10408 Document #: 125-1 Filed: 03/24/23 Page 51 of 51 PageID #:587
</FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">reason exists for delay in entering the Judgment in accordance with the Stipulation. Accordingly, the Clerk is hereby directed to enter this
Judgment forthwith in accordance with Rule 58 of the Federal Rules of Civil Procedure. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><B>IT IS SO ORDERED. </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="37%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="62%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top">DATED:</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">&nbsp;HONORABLE NANCY L. MALDONADO</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P ALIGN="justify" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:12pt">&nbsp;U.S. DISTRICT JUDGE</P></TD></TR>
</TABLE> <P STYLE="margin-top:200pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">1613290 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.2
<SEQUENCE>3
<FILENAME>d468351dex992.htm
<DESCRIPTION>EX-99.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 99.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 1
 of 12 PageID #:622 </FONT></P> <P STYLE="margin-top:40pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES DISTRICT COURT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>NORTHERN DISTRICT OF ILLINOIS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>EASTERN DIVISION </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">COREY CUTLER AS PERSONAL REPRESENTATIVE OF THE ESTATE OF ANNE SHIRLEY CUTLER, Derivatively on Behalf of WALGREEN CO.,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-10408</FONT></FONT></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:10.00em; font-size:12pt; font-family:Times New Roman">Plaintiff,</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP>Hon. Nancy L. Maldonado</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; font-size:12pt; font-family:Times New Roman">v.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">GREGORY D. WASSON, JAMES A. SKINNER, WILLIAM C. FOOTE, STEFANO PESSINA, ALAN G. MCNALLY, NANCY M. SCHLICHTING, ALEJANDRO SILVA, STEPHEN A. DAVIS, MARK P. FRISSORA, GINGER L.
GRAHAM, DAVID J. BRAILER, DOMINIC P. MURPHY, JANICE M. BABIAK, WADE D. MIQUELON, and DAVID Y. SCHWARTZ,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:12pt; font-family:Times New Roman"><B>EXHIBIT C</B></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:10.00em; font-size:12pt; font-family:Times New Roman">Defendants,</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; font-size:12pt; font-family:Times New Roman">&#150; and &#150;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">WALGREEN CO., a Illinois corporation,</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24" STYLE="BORDER-RIGHT:1px solid #000000; padding-left:8pt">&nbsp;</TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top" STYLE="BORDER-RIGHT:1px solid #000000; BORDER-BOTTOM:1px solid #000000; padding-left:8pt"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:10.00em; font-size:12pt; font-family:Times New Roman">Nominal Defendant.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>AMENDED NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B><U>SHAREHOLDER DERIVATIVE ACTION</U> </B></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 2
 of 12 PageID #:623 </FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>TO:</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>ALL OWNERS OF THE COMMON STOCK OF WALGREENS (THE &#147;COMPANY&#148;) CURRENTLY AND AS OF MARCH&nbsp;22,
2023 (&#147;CURRENT WALGREENS SHAREHOLDERS&#148;): </B></P></TD></TR></TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><B>THIS NOTICE RELATES TO THE PENDENCY AND PROPOSED SETTLEMENT OF
SHAREHOLDER DERIVATIVE LITIGATION. PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY. IF YOU ARE A WALGREENS SHAREHOLDER, THIS NOTICE CONTAINS IMPORTANT INFORMATION ABOUT YOUR RIGHTS. </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:5%; font-size:12pt; font-family:Times New Roman"><B>THIS ACTION IS NOT A &#147;CLASS ACTION.&#148; THUS, THERE IS NO COMMON FUND UPON WHICH YOU CAN MAKE A CLAIM FOR A MONETARY PAYMENT.
</B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>YOU ARE HEREBY NOTIFIED</B>, pursuant to an Order of the U.S. District Court for the Northern District of Illinois
(the &#147;Court&#148;), that a proposed settlement has been reached by the parties to the following shareholder derivative action brought on behalf and for the benefit of Walgreens: <I>Corey Cutler as Personal Representative of the Estate of Anne
Shirley Cutler v. </I><I>Wasson, et al.</I>, Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-1040</FONT></FONT> (the &#147;Action&#148;).<SUP STYLE="font-size:75%; vertical-align:top">1</SUP> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">As explained below, a hearing will be held on July&nbsp;25, 2023 at 10:00 a.m., before the Honorable Nancy L. Maldonado at the
U.S. District Court for the Northern District of Illinois, Everett McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Courtroom 1925, Chicago, Illinois 60604 (the &#147;Settlement Hearing&#148;), at which the Court will determine:
(i)&nbsp;whether the terms of the Settlement are fair, reasonable, and adequate and should be approved; (ii)&nbsp;whether a final order and judgment should be entered, dismissing the Action with prejudice and extinguishing and fully and finally
releasing all of the Released Claims against the Released Persons; (iii)&nbsp;whether the Court should award the requested attorneys&#146; fees and reimbursement of expenses for Plaintiff&#146;s Counsel and service award to the Plaintiff; and (iv)
such other actions as may be necessary or proper under the circumstances. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:24%">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><SUP
STYLE="font-size:75%; vertical-align:top">1</SUP> All capitalized terms herein have the same meanings as set forth Parties&#146; Stipulation of Settlement dated March&nbsp;22, 2023 (the &#147;Stipulation&#148;), which is available for viewing on the
website of Walgreens at www. investor.walgreensbootsalliance.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 1 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 3
 of 12 PageID #:624 </FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The terms of the Settlement are set forth in the Stipulation and summarized in this Notice. The Settlement provides for
corporate governance reforms relating to Walgreens&#146; disclosure-related policies and procedures. The Reforms, among other things: (i)&nbsp;require that Walgreens retain outside counsel every two years to evaluate all of Walgreens&#146;
disclosure-related policies and procedures, including an assessment as to whether those policies and procedures are consistent with or exceed industry best standards, and whether those policies provide for routine and timely communication between
management and the Board and Directors regarding the Company&#146;s long-term financial goals, performance, material risks, and other important issues relevant to the Company&#146;s disclosures; (ii)&nbsp;require training for directors and certain
senior officers regarding disclosure-related laws, regulations, policies, and procedures; and (iii)&nbsp;strengthened several of Walgreens&#146; disclosure-related policies and procedures, including policies specific to earnings calls, what may be
disclosed in small group meetings with analysts, and when and how the Company may update or confirm financial guidance. <I>See</I> Stipulation, Ex. A. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">If approved by the Court, the Settlement will fully resolve the Action, including the dismissal of the Action with prejudice.
For a more detailed statement of the matters involved in the Action, the Settlement, and the terms discussed in this Notice, the Stipulation may be inspected at the Clerk of Court&#146;s office, U.S. District Court for the Northern District of
Illinois, Everett McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Chicago, Illinois 60604. The Stipulation is also available for viewing on the website of Walgreens at www. investor.walgreensbootsalliance.com. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 2 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 4
 of 12 PageID #:625 </FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">This Notice is not intended to be an expression of any opinion by the Court with respect to the merits of the claims made in
the Action, but is merely to advise you of the pendency and settlement of the Action. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><B>THERE IS NO CLAIMS PROCEDURE.</B>
This case was brought to protect the interests of Walgreens. The Settlement will result in changes to the Company&#146;s corporate governance, not in payment to individuals, and accordingly, there will be no claims procedure. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>I.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>BACKGROUND OF THE ACTION </B></P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>A.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Proceedings in this Action </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">On December&nbsp;29, 2014, Anne Cutler<SUP STYLE="font-size:75%; vertical-align:top">2</SUP> filed a shareholder derivative
complaint (&#147;Complaint&#148;) derivatively on behalf of Walgreens against certain of the Company&#146;s current and former officers and directors for alleged breaches of fiduciary duty, waste of corporate assets, and unjust enrichment in
connection with their alleged failure to disclose material information concerning the Company&#146;s future business prospects. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Defendants filed motions to dismiss the Complaint on April&nbsp;10, 2015, and a motion for a protective order staying discovery
on April&nbsp;13, 2015. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The Parties then engaged in discussions regarding scheduling and the coordination of this
derivative action with the related Securities Action, titled <I>Washtenaw County Employees&#146; Retirement System v. Walgreen Co.</I>, Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:15-cv-03187,</FONT></FONT> which was
pending before the Court. On May&nbsp;18, 2015, the Court entered an order approving the Parties&#146; stipulation to stay this shareholder derivative action pending resolution of the motion to dismiss the Securities Action. Thereafter, on
November&nbsp;3, 2016, the Court entered an order approving the Parties&#146; stipulation to stay this action pending final resolution of the Securities Action. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:24%">&nbsp;</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify"><SUP
STYLE="font-size:75%; vertical-align:top">2</SUP> Anne Cutler died on November&nbsp;4, 2018. On May&nbsp;31, 2019, the Court granted Plaintiff&#146;s motion to substitute Ms.&nbsp;Cutler&#146;s son, Corey Cutler, as Personal Representative of the
Estate of Anne Shirley Cutler. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 3 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 5
 of 12 PageID #:626 </FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="6%" VALIGN="top" ALIGN="left"><B>B.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>Settlement Efforts </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Shortly after the Court granted in part the defendants&#146; motion for summary judgment in the Securities Action, the Parties
commenced negotiations to settle this Action. The Parties engaged in significant <FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiations regarding certain corporate governance reforms with the supervision and assistance of
highly-experienced and well-respected mediators Hon. Layn R. Phillips (Ret.) and Niki Mendoza from Phillips ADR. After several months, during which the Parties exchanged proposals and counter-proposals and Plaintiff&#146;s Counsel reviewed the
Company&#146;s pertinent <FONT STYLE="white-space:nowrap">non-public</FONT> disclosure policies, the Parties reached an agreement on the Reforms (defined below) to be implemented as part of the proposed Settlement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Thereafter, the Parties negotiated the formal operative terms of the Settlement as set forth in the Stipulation and commenced <FONT
STYLE="white-space:nowrap">arm&#146;s-length</FONT> negotiations regarding an appropriate amount of attorneys&#146; fees and expenses to be paid to Plaintiff&#146;s Counsel in recognition of the benefits conferred by the Settlement. The fee
negotiations were facilitated and supervised by mediator Niki Mendoza and culminated in the Parties&#146; agreement to a Fee and Expense Amount of $950,000, subject to Court approval. </P>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>II.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>PLAINTIFF&#146;S CLAIMS AND THE BENEFITS OF SETTLEMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Plaintiff believes that the Action has substantial merit, and Plaintiff&#146;s entry into this Stipulation and Settlement is
not intended to be and shall not be construed as an admission or concession concerning the relative strength or merit of the claims alleged in the Action. However, Plaintiff and Plaintiff&#146;s Counsel recognize and acknowledge the significant
risk, expense, and length of continued proceedings necessary to prosecute the Action against the Individual Defendants through trial and possible appeals. Plaintiff&#146;s Counsel have also taken into account
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 4 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 6
 of 12 PageID #:627 </FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">the uncertain outcome and the risk of any litigation, especially in complex cases such as the Action, as well as the difficulties and delays
inherent in such litigation. Plaintiff&#146;s Counsel are also mindful of the inherent problems of establishing standing to pursue this derivative action, and the possible defenses to the claims alleged. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Plaintiff&#146;s Counsel have conducted extensive investigation and analysis, including, <I>inter alia</I>: (i)&nbsp;reviewing
Walgreens&#146;<B> </B>press releases, public statements, U.S. Securities and Exchange Commission (&#147;SEC&#148;) filings, and securities analysts&#146; reports and advisories about the Company; (ii)&nbsp;reviewing related media reports about the
Company; (iii)&nbsp;reviewing <FONT STYLE="white-space:nowrap">non-public</FONT> documents produced in connection with the related Securities Action; (iv)&nbsp;researching applicable law with respect to the claims alleged in the Action and potential
defenses thereto; (iv)&nbsp;reviewing and analyzing the allegations and pleadings filed in the related Securities Action; (v)&nbsp;preparing and filing a derivative complaint; (vi)&nbsp;conducting damages analyses; and (vii)&nbsp;negotiating this
Settlement with Defendants, including researching corporate governance best practices and negotiating the Reforms. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Based
on Plaintiff&#146;s Counsel&#146;s thorough review and analysis of the relevant facts, allegations, defenses, and controlling legal principles, Plaintiff&#146;s Counsel believe that the Settlement set forth in the Stipulation is fair, reasonable,
and adequate, and confers substantial benefits upon Walgreens. Based upon Plaintiff&#146;s Counsel&#146;s evaluation, Plaintiff has determined that it believes the Settlement is in the best interests of Walgreens<B> </B>and has agreed to settle the
Action upon the terms and subject to the conditions set forth in the Stipulation. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>III.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>DEFENDANTS&#146; DENIALS OF WRONGDOING AND LIABILITY </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Defendants have denied and continue to deny each and all of the claims alleged by Plaintiff in the Action, including that there
was any wrongdoing, any liability, or any harm to Walgreens. In particular, the Individual Defendants have expressly denied and continue to deny all charges of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 5 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 7
 of 12 PageID #:628 </FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">wrongdoing or liability against them, and any harm to Walgreens, arising out of any of the conduct, statements, acts, or omissions alleged, or
that could have been alleged, in the Action. Nonetheless, Defendants have concluded that further litigation would be protracted, expensive, and distracting, and have also taken into account the uncertainty and risks inherent in any litigation,
especially in complex cases like the Action. Defendants have, therefore, determined that the Settlement confers a substantial benefit upon Walgreens and its shareholders, and the Settlement, and each of its terms, is in all respects fair,
reasonable, and in the best interests of Walgreens and its shareholders. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Neither the Stipulation, nor any of its terms or
provisions, nor entry of the Judgment, nor any document or exhibit referred or attached to the Stipulation, nor any action taken to carry out the Stipulation, is, may be construed as, or may be used as evidence of the validity of any of the Released
Claims or an admission by or against any of the Defendants of any fault, wrongdoing, or concession of liability whatsoever. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>IV.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>TERMS OF THE SETTLEMENT </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The terms and conditions of the proposed Settlement are set forth in the Stipulation, which has been filed with the Court and
is available for viewing on Walgreens&#146; website at www.investor.walgreensbootsalliance.com. The following is only a summary of its terms. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Pursuant to the Settlement, and in consideration for the Settlement and release of all the Released Claims, Walgreens has
agreed to implement and maintain the corporate governance reforms set forth in Exhibit A to the Stipulation (&#147;Reforms&#148;) for a period of no less than five (5)&nbsp;years. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Walgreens<B> </B>acknowledges that, unless otherwise stated in Exhibit A, the prosecution and settlement of the Action was the
sole factor<B> </B>in the agreement to adopt and/or implement the Reforms. The Defendants further acknowledge and agree that the Settlement confers a substantial benefit upon Walgreens and its shareholders, and the Settlement, and each of its terms,
is in all respects fair, reasonable, and in the best interests of Walgreens and its shareholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 6 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 8
 of 12 PageID #:629 </FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">For a complete description of all of the Reforms, please see Exhibit A to the Stipulation, which is available for viewing on
Walgreens&#146; website at www.investor.walgreensbootsalliance.com. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>V.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>DISMISSAL AND RELEASES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The Settlement is conditioned upon the occurrence of certain events, which include, among other things, entry of an order by
the Court approving the Settlement and dismissing the Action with prejudice. The Settlement will not become effective until such an order has been entered and become final and <FONT STYLE="white-space:nowrap">non-appealable</FONT> (the
&#147;Effective Date&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Upon the Effective Date, the Releasing Parties shall be deemed to have fully, finally, and
forever released, relinquished, and discharged the Released Claims (including Unknown Claims) against the Released Persons, and any and all claims arising out of, relating to, or in connection with the defense, settlement, or resolution of the
Action against the Released Persons. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">In addition, upon the Effective Date, each of the Defendants shall be deemed to have
fully, finally, and forever released, relinquished, and discharged Plaintiff and Plaintiff&#146;s Counsel from all claims (including Unknown Claims), arising out of, relating to, or in connection with the institution, prosecution, assertion,
settlement, or resolution of the Action or the Released Claims. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Nothing in these releases, however, shall in any way
impair or restrict the rights of any Party to enforce the terms of the Stipulation. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>VI.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>PLAINTIFF&#146;S ATTORNEYS&#146; FEES AND EXPENSES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">After negotiating the substantive terms of the Settlement, including the Reforms, the Parties commenced negotiations regarding
the attorneys&#146; fees and expenses to be paid to Plaintiff&#146;s Counsel. These negotiations, which were overseen by mediators Hon. Layn R. Phillips (Ret.) and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 7 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 9
 of 12 PageID #:630 </FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Niki Mendoza from Phillips ADR, concluded with Walgreens and/or the Defendants&#146; insurers agreement to pay Plaintiff&#146;s Counsel&#146;s
attorneys&#146; fees and expenses in the total amount of $950,000 (the &#147;Fee and Expense Amount&#148;), subject to Court approval. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Plaintiff&#146;s Counsel may also apply to the Court for a service award of up to $2,500 for Plaintiff, only to be paid upon
Court approval, and to be paid from the Fee and Expense Amount in recognition of Plaintiff&#146;s participation and effort in the prosecution of the Action. Neither Walgreens nor any of the Individual Defendants shall be liable for any portion of
any service award. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">To date, Plaintiff&#146;s Counsel have neither received any payment for their services in conducting
the Action, nor been reimbursed for their <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>VII.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>THE SETTLEMENT HEARING </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">The Settlement Hearing will be held before the Honorable Nancy L. Maldonado at the U.S. District Court for the Northern
District of Illinois, Everett McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Courtroom 1925, Chicago, Illinois 60604, at which the Court will determine: (i)&nbsp;whether the terms of the Stipulation should be approved as fair,
reasonable, and adequate; (ii)&nbsp;whether the Notice fully satisfied the requirements of Rule 23.1 of the Federal Rules of Civil Procedure and the requirements of due process; (iii)&nbsp;whether all Released Claims against the Released Persons
should be fully and finally released; (iv)&nbsp;whether the <FONT STYLE="white-space:nowrap">agreed-to</FONT> Fee and Expense Amount should be approved; and (v)&nbsp;such other matters as the Court may deem appropriate. The Settlement Hearing may be
continued by the Court at the Settlement Hearing, or at any adjourned session thereof, without further notice. </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>VIII.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>THE RIGHT TO ATTEND AND/OR OBJECT AT THE SETTLEMENT HEARING </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">You have the right, but are not required, to appear in person or through counsel at the Settlement Hearing to object to the
terms of the proposed Settlement or otherwise present evidence </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 8 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 10
 of 12 PageID #:631 </FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="justify">or argument that may be proper and relevant. If you want to be heard at the Settlement Hearing, then you must first comply with the procedures
for objecting, which are set forth below. The Court has the right to change the hearing date, time, or platform (in person, by video or telephone conference) without further notice. Thus, if you are planning to participate in the Settlement Hearing,
you should confirm the date, time and platform before going to the Court, and you may consult the Court&#146;s calendar for any change in date or time of, or platform used for, the Settlement Hearing. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Unless otherwise ordered by the Court, you shall be heard or entitled to contest the approval of the proposed Settlement, or,
if approved, the Order and Final Judgment to be entered thereon, or the amount of attorneys&#146; fees and reimbursement of expenses to Plaintiff&#146;s Counsel, only if you have, <B><I>at least fourteen
(14)</I></B><B><I></I></B><B><I>&nbsp;calendar days prior to the Settlement Hearing</I></B>, filed with the Court a written notice of objection containing the following information: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">1.&nbsp;&nbsp;&nbsp;&nbsp; Your name, legal address, and telephone number; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">2.&nbsp;&nbsp;&nbsp;&nbsp; The case name and number (<I>Corey Cutler as Personal Representative of the Estate of Anne Shirley
Cutler v. Wasson, et al.</I>, Case No. <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1:14-cv-10408);</FONT></FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">3.&nbsp;&nbsp;&nbsp;&nbsp; Proof of being a Walgreens shareholder currently and as of March&nbsp;22, 2023; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">4.&nbsp;&nbsp;&nbsp;&nbsp; The date(s) you acquired your Walgreens shares; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">5.&nbsp;&nbsp;&nbsp;&nbsp; A statement of each of each objection being made; </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">6.&nbsp;&nbsp;&nbsp;&nbsp; Notice of whether you intend to appear at the Settlement Hearing, and whether you are represented by
counsel and if so, contact information for your counsel (you are not required to appear); and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 9 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 11
 of 12 PageID #:632 </FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">7.&nbsp;&nbsp;&nbsp;&nbsp; Copies of any papers you intend to submit to the Court, along with the names of any witness(es) you
intend to call to testify at the Settlement Hearing and the subject(s) of their testimony. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">If you wish to object to the
proposed Settlement, you must file the written objection described above with the Court on or before July&nbsp;11, 2023. All written objections and supporting papers must be filed with the Clerk of the Court, U.S. District Court for the Northern
District of Illinois, Everett McKinley Dirksen United States Courthouse, 219 South Dearborn Street, Chicago, Illinois 60604. You must also serve copies of the same materials by hand delivery, overnight mail, or the court&#146;s electronic filing and
service system so they are received no later than July&nbsp;11, 2023 by the following counsel for Plaintiff and Defendants: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="3%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>Counsel for Plaintiff:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"><I>Counsel for Defendants:</I></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ROBBINS LLP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">SIDLEY AUSTIN LLP</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">ASHLEY R. RIFKIN</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">JOHN M. SKAKUN III</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">5060 Shoreham Place, Suite 300</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">One South Dearborn Street</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">San Diego, CA 92122</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chicago, IL 60603</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Telephone: (619) <FONT STYLE="white-space:nowrap">525-3990</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Telephone: (312) <FONT STYLE="white-space:nowrap">853-7000</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Facsimile: (619) <FONT STYLE="white-space:nowrap">525-3991</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Facsimile: (312) <FONT STYLE="white-space:nowrap">853-7036</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">YOUR WRITTEN OBJECTIONS MUST BE ON FILE WITH THE CLERK OF THE COURT AND RECEIVED BY COUNSEL NO
LATER THAN July&nbsp;11, 2023. Only shareholders who have filed and delivered valid and timely written notices of objection will be entitled to be heard at the Settlement Hearing unless the Court orders otherwise. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">Unless otherwise ordered by the Court, any shareholder who does not make his, her, or its objection in the manner provided
herein shall be deemed to have waived such objection and shall forever be barred and foreclosed from making any objection to the fairness, reasonableness, or adequacy of the Settlement, unless otherwise ordered by the Court, and shall otherwise be
bound by the Final Order and Judgment to be entered and the releases to be given. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 10 - </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always">
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:ARIAL" ALIGN="center"><FONT COLOR="#0000ff"> Case: 1:14-cv-10408 Document #: 128 Filed: 05/02/23 Page
 12
 of 12 PageID #:633 </FONT></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%" VALIGN="top" ALIGN="left"><B>IX.</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman; " ALIGN="left"><B>EXAMINATION OF PAPERS AND INQUIRIES </B></P></TD></TR></TABLE>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:5%; font-size:12pt; font-family:Times New Roman" ALIGN="justify">There is additional information concerning the Settlement available in the Stipulation, which is available for viewing on
Walgreens&#146; website at www.investor.walgreensbootsalliance.com. You may also inspect the Stipulation during business hours at the office of the Clerk of the Court, U.S. District Court for the Northern District of Illinois, Everett McKinley
Dirksen United States Courthouse, 219 South Dearborn Street, Courtroom 1925, Chicago, Illinois 60604. Or you can call Robbins LLP, 5060 Shoreham Place, Suite 300, San Diego, California 92122, telephone: (619)
<FONT STYLE="white-space:nowrap">525-3990,</FONT> for additional information concerning the Settlement. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>PLEASE DO NOT CONTACT THE COURT
OR WALGREENS </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>REGARDING THIS NOTICE. </B></P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:12pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="9%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">DATED:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:12pt; font-family:Times New Roman" ALIGN="right">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">BY ORDER OF THE UNITED STATES DISTRICT</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:12pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:12pt; font-family:Times New Roman">COURT FOR THE NORTHERN DISTRICT OF ILLINOIS</P></TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center">- 11 - </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>wba-20230526.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/26/2023 5:59:54 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:wba="http://walgreensbootsalliance.com/20230526"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://walgreensbootsalliance.com/20230526"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd" namespace="http://fasb.org/us-gaap/2022" />
    <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd" namespace="http://fasb.org/us-types/2022" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wba-20230526_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wba-20230526_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="wba-20230526_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="wba_DocumentAndEntityInformationTable" name="DocumentAndEntityInformationTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="wba_DocumentAndEntityInformationLineItems" name="DocumentAndEntityInformationLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="wba_A3600NotesPayableDue2025Member" name="A3600NotesPayableDue2025Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
  <xsd:element id="wba_A2125NotesPayableDue2026Member" name="A2125NotesPayableDue2026Member" type="nonnum:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true" />
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>wba-20230526_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/26/2023 5:59:56 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<linkbase xmlns="http://www.xbrl.org/2003/linkbase" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:roleRef roleURI="http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="wba-20230526.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:definitionLink xlink:type="extended" xlink:role="http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="wba-20230526.xsd#wba_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationTable" />
    <link:loc xlink:href="wba-20230526.xsd#wba_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationLineItems" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain_2" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:loc xlink:href="wba-20230526.xsd#wba_A3600NotesPayableDue2025Member" xlink:type="locator" xlink:label="wba_A3600NotesPayableDue2025Member" />
    <link:loc xlink:href="wba-20230526.xsd#wba_A2125NotesPayableDue2026Member" xlink:type="locator" xlink:label="wba_A2125NotesPayableDue2026Member" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="wba_DocumentAndEntityInformationTable" order="1" priority="2" use="optional" xbrldt:contextElement="segment" xbrldt:closed="true" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_2" order="23.0001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_A3600NotesPayableDue2025Member" order="25" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_A2125NotesPayableDue2026Member" order="26" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="33.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="34.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="35.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" />
    <definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" />
  </link:definitionLink>
</linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>wba-20230526_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/26/2023 5:59:54 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="wba-20230526.xsd#wba_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationTable" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="wba_DocumentAndEntityInformationTable_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Table]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationTable_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Table]</link:label>
    <link:loc xlink:href="wba-20230526.xsd#wba_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationLineItems" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="wba_DocumentAndEntityInformationLineItems_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document And Entity Information [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_DocumentAndEntityInformationLineItems_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document And Entity Information [Line Items]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Axis]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock [Domain]</link:label>
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl" />
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="us-gaap_CommonStockMember_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock [Member]</link:label>
    <link:loc xlink:href="wba-20230526.xsd#wba_A3600NotesPayableDue2025Member" xlink:type="locator" xlink:label="wba_A3600NotesPayableDue2025Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_A3600NotesPayableDue2025Member" xlink:to="wba_A3600NotesPayableDue2025Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_A3600NotesPayableDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">A 3600 Notes Payable Due 2025 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_A3600NotesPayableDue2025Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">A 3600 Notes Payable Due 2025 [Member]</link:label>
    <link:loc xlink:href="wba-20230526.xsd#wba_A2125NotesPayableDue2026Member" xlink:type="locator" xlink:label="wba_A2125NotesPayableDue2026Member" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="wba_A2125NotesPayableDue2026Member" xlink:to="wba_A2125NotesPayableDue2026Member_lbl" />
    <link:label xml:lang="en-US" xlink:label="wba_A2125NotesPayableDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">A 2125 Notes Payable Due 2026 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:label="wba_A2125NotesPayableDue2026Member_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">A 2125 Notes Payable Due 2026 [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>wba-20230526_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 5/26/2023 5:59:54 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="wba-20230526.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="wba-20230526.xsd#wba_DocumentAndEntityInformationTable" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationTable" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="wba_DocumentAndEntityInformationTable" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="wba-20230526.xsd#wba_DocumentAndEntityInformationLineItems" xlink:type="locator" xlink:label="wba_DocumentAndEntityInformationLineItems" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="wba_DocumentAndEntityInformationLineItems" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis" xlink:type="locator" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain" xlink:type="locator" xlink:label="us-gaap_ClassOfStockDomain" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember" xlink:type="locator" xlink:label="us-gaap_CommonStockMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_CommonStockMember" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="wba-20230526.xsd#wba_A3600NotesPayableDue2025Member" xlink:type="locator" xlink:label="wba_A3600NotesPayableDue2025Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_A3600NotesPayableDue2025Member" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="wba-20230526.xsd#wba_A2125NotesPayableDue2026Member" xlink:type="locator" xlink:label="wba_A2125NotesPayableDue2026Member" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="wba_A2125NotesPayableDue2026Member" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_AmendmentFlag" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityCentralIndexKey" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentType" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_DocumentPeriodEndDate" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityRegistrantName" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityIncorporationStateCountryCode" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityFileNumber" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityTaxIdentificationNumber" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressAddressLine1" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressCityOrTown" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressStateOrProvince" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityAddressPostalZipCode" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_CityAreaCode" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_LocalPhoneNumber" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_WrittenCommunications" order="45.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SolicitingMaterial" order="46.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementTenderOffer" order="47.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_PreCommencementIssuerTenderOffer" order="48.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_Security12bTitle" order="49.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_TradingSymbol" order="50.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_SecurityExchangeName" order="51.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="wba_DocumentAndEntityInformationLineItems" xlink:to="dei_EntityEmergingGrowthCompany" order="52.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140201640853600">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 26, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001618921<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 26,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">WALGREENS BOOTS ALLIANCE, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36759<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">47-1758322<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">108 Wilmot Road<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Deerfield<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">IL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">60015<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(847)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">315-2500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, $0.01 par value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WBA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wba_A3600NotesPayableDue2025Member', window );">A 3600 Notes Payable Due 2025 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">3.600% Walgreens Boots Alliance, Inc. notes due 2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WBA25<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=wba_A2125NotesPayableDue2026Member', window );">A 2125 Notes Payable Due 2026 [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_wba_DocumentAndEntityInformationLineItems', window );"><strong>Document And Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">2.125% Walgreens Boots Alliance, Inc. notes due 2026<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">WBA26<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_wba_DocumentAndEntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">wba_DocumentAndEntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>wba_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wba_A3600NotesPayableDue2025Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wba_A3600NotesPayableDue2025Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=wba_A2125NotesPayableDue2026Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=wba_A2125NotesPayableDue2026Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d468351d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:wba="http://walgreensbootsalliance.com/20230526"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="wba-20230526.xsd" xlink:type="simple"/>
    <context id="duration_2023-05-26_to_2023-05-26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
        </entity>
        <period>
            <startDate>2023-05-26</startDate>
            <endDate>2023-05-26</endDate>
        </period>
    </context>
    <context id="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-26</startDate>
            <endDate>2023-05-26</endDate>
        </period>
    </context>
    <context id="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A3600NotesPayableDue2025Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:A3600NotesPayableDue2025Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-26</startDate>
            <endDate>2023-05-26</endDate>
        </period>
    </context>
    <context id="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A2125NotesPayableDue2026Member">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001618921</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">wba:A2125NotesPayableDue2026Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-05-26</startDate>
            <endDate>2023-05-26</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-05-26_to_2023-05-26">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-05-26_to_2023-05-26"
      id="Hidden_dei_EntityCentralIndexKey">0001618921</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-05-26_to_2023-05-26">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-05-26_to_2023-05-26">2023-05-26</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-05-26_to_2023-05-26">WALGREENS BOOTS ALLIANCE, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-05-26_to_2023-05-26">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-05-26_to_2023-05-26">001-36759</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-05-26_to_2023-05-26">47-1758322</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-05-26_to_2023-05-26">108 Wilmot Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-05-26_to_2023-05-26">Deerfield</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-05-26_to_2023-05-26">IL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-05-26_to_2023-05-26">60015</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-05-26_to_2023-05-26">(847)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-05-26_to_2023-05-26">315-2500</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-05-26_to_2023-05-26">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-05-26_to_2023-05-26">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-05-26_to_2023-05-26">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-05-26_to_2023-05-26">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">Common Stock, $0.01 par value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">WBA</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_us-gaap-CommonStockMember">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A3600NotesPayableDue2025Member">3.600% Walgreens Boots Alliance, Inc. notes due 2025</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A3600NotesPayableDue2025Member">WBA25</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A3600NotesPayableDue2025Member">NASDAQ</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A2125NotesPayableDue2026Member">2.125% Walgreens Boots Alliance, Inc. notes due 2026</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A2125NotesPayableDue2026Member">WBA26</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-05-26_to_2023-05-26_us-gaap-StatementClassOfStockAxis_wba-A2125NotesPayableDue2026Member">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-05-26_to_2023-05-26">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=8[)V@.?"PUY \012RNY<)VG\/;#PV PFI"K^_O'"0EO;X?AJ#\X(<-1OXZ
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MIOGA@C-8"]L+X/<9I.GUQ&YU%_^IZ/T-4$L#!!0    ( "J(NE:?H!OPL0(
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M-4H2U\7!ZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U
M.EK >MKBRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*
M$3FQ!'_'G2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87
M_QO.\1'"[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( "J(NE8'04UB@0
M +$    0              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#
M%     @ *HBZ5B,[A CN    *P(  !$              ( !KP   &1O8U!R
M;W!S+V-O<F4N>&UL4$L! A0#%     @ *HBZ5IE<G",0!@  G"<  !,
M         ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    "  J
MB+I6C[8K(C$%  "U&   &               @($-"   >&PO=V]R:W-H965T
M<R]S:&5E=#$N>&UL4$L! A0#%     @ *HBZ5I^@&_"Q @  X@P   T
M         ( != T  'AL+W-T>6QE<RYX;6Q02P$"% ,4    "  JB+I6EXJ[
M',     3 @  "P              @ %0$   7W)E;',O+G)E;'-02P$"% ,4
M    "  JB+I6'#AEZC\!   \ @  #P              @ $Y$0  >&PO=V]R
M:V)O;VLN>&UL4$L! A0#%     @ *HBZ5B0>FZ*M    ^ $  !H
M     ( !I1(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#%
M  @ *HBZ5F60>9(9 0  SP,  !,              ( !BA,  %M#;VYT96YT
A7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  U!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>4</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>3</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d468351d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="d468351d8k.htm">d468351d8k.htm</File>
    <File>d468351dex991.htm</File>
    <File>d468351dex992.htm</File>
    <File>wba-20230526.xsd</File>
    <File>wba-20230526_def.xml</File>
    <File>wba-20230526_lab.xml</File>
    <File>wba-20230526_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "d468351d8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 28
   },
   "contextCount": 4,
   "dts": {
    "definitionLink": {
     "local": [
      "wba-20230526_def.xml"
     ]
    },
    "inline": {
     "local": [
      "d468351d8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "wba-20230526_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "wba-20230526_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "wba-20230526.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    }
   },
   "elementCount": 30,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 2,
   "memberStandard": 1,
   "nsprefix": "wba",
   "nsuri": "http://walgreensbootsalliance.com/20230526",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d468351d8k.htm",
      "contextRef": "duration_2023-05-26_to_2023-05-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "d468351d8k.htm",
      "contextRef": "duration_2023-05-26_to_2023-05-26",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 3,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock [Member]"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "wba_A2125NotesPayableDue2026Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "A 2125 Notes Payable Due 2026 [Member]",
        "terseLabel": "A 2125 Notes Payable Due 2026 [Member]"
       }
      }
     },
     "localname": "A2125NotesPayableDue2026Member",
     "nsuri": "http://walgreensbootsalliance.com/20230526",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "wba_A3600NotesPayableDue2025Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "A 3600 Notes Payable Due 2025 [Member]",
        "terseLabel": "A 3600 Notes Payable Due 2025 [Member]"
       }
      }
     },
     "localname": "A3600NotesPayableDue2025Member",
     "nsuri": "http://walgreensbootsalliance.com/20230526",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "wba_DocumentAndEntityInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Line Items]",
        "terseLabel": "Document And Entity Information [Line Items]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationLineItems",
     "nsuri": "http://walgreensbootsalliance.com/20230526",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "wba_DocumentAndEntityInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document And Entity Information [Table]",
        "terseLabel": "Document And Entity Information [Table]"
       }
      }
     },
     "localname": "DocumentAndEntityInformationTable",
     "nsuri": "http://walgreensbootsalliance.com/20230526",
     "presentation": [
      "http://walgreensbootsalliance.com//20230526/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-23-155537-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-155537-xbrl.zip
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MH/*8@G<<_Q5EAB?418SJJ*#:N4PIW@\\E#+SK2>1%5 /V7CLYT;*C5.I=*3
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M2FL/S(%YY$G=8ZS@&Q7W-(90N<+0"L'!?M&1)'\5"O71*X_4UY6P1JM-ZOW
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M#QG5TS=<-R"6J,V6[78,15(6RQ*I(:ER>]YX/X $**(, BPLDE6__IXE,Y$
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M*9?1,UJ_C?R*"!U5$.6HL1.A6&+&6%B7R=Q"O)<P7&^<A!FM[/-^P_:<4/S
M<JQFJXE\A2;2W%Q-)'.PB_8$'7;QANH;ZN9D0B6/N. G#^ $2NTJ730KYSX%
MP05[,T9C*G"O831;0ZSZXGGJJ^B9S;YJ6'HQF/O$!V&7UZH,=C23C';'AS&2
MJ5(7<A/(#$:E4670^34*T\"&:<-C"'3'F6WX?&&@O2T,M&$PT&$9!JK_-##0
M-S&K. 7%]L:+E7('!HL'%A+>2-BRJ7<]]>]V2/OUB+O00V@B[<AX(C2JP#ZT
MR8M&V5SG]ET@^C5Q.<5XG7DL7H U4V-W3=?[[(D+8'WAWV W1>$L>ZK1ZM=
MC2:F&6/$!^AX,UC*%$PN!S@?,!#6%DRNYWX93^T F1=H#_,PMGT5WY$B*>WD
M/RUAW4T9"!6Y-YY[*WESP:^&BK\7N/=AB$$8[,S3D>^-%2>4#CUTS,U#^)S"
ML\P%2&4)C$136PJ5I<T\L8"%20O40TL%'\=3B5GKEDHP+YML="4TGURA--$N
M8P<R<26WG_R=O@CG)/]N5-2.AJ6T%F";L3O*!6\&&S$A2+'X^.(,3PR5UGGD
MD1MXAC1'M@/L8!2X=TJV3\"NUU8DT%O,!XC&D^?@STOIT@M(&P"9;)HX(S<
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MLR!J"L?!MX)DC;T1W%R&A.+:\N5-;?0=^3&<J_W9#?B([3%I)_3.-- P<YJ
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MZH8R,#?G]9<-KM>'Z3(:8'C..4Z#([RK%14J9R>R8F%X*[B485;Q1"NDL3A
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M0ST%:U&6&8=S &>])IM/YQ<2(S8GJ;L4E'S8U0K=+K U*,$K2HW.:4]Z7*M
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M"_99XB/&[-DSU+M/PQ#[G P2=V('H;C$W/3 MD3#MP/QOB8NQEUN9=*U,9L
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MB*>9&)*/P)(6:\V6M0_D:% 3$5=E6[.X>RA:7[>Z7O^RUV\,V^)][X]VO]M
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M/1*LX,!& M<M5:; _4(E&^9A3**>D_% D&.9AK%;K7 =1?@[/H9@BB0F[K#
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MTSL5G?/S3K?7&3S1G-J-P9"GQ/ZK-7S\P9Q**_1%/;NHA^>NLZ&O/ZXA4-@
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M']4JAV+ 92>@H:002.XA>53F\&@W$9$Z1=QB[>5]M?/!4O<6!RR^&:@,.\0
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M%W5X55YB6F)NWF)22R/:6QSCK%0D7 Z.3TB&DW.Y:9N!YIXE,S" HD$,CKH
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MJO6U=$W*"*Z8>.O/"4MP/SH'U4/ >Z/D;(EY/(GKB]BF)I!-*1H+/];.!?H
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M6EP1<6ZTOH8 ).GR29$"#& 0""P;=NU@G@X),TH:?[_ZY)APQ5ERKY2L136
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M.,S:"S;EM^XSY4&KNZUS^/"X>]+>_S]02P,$%     @ *HBZ5IDK;+UB)0
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M#+!%EQ&"Z#?NTC\_E.1"US#1?1B@9)ZNV5?W&H)78(P7?1RI!82@QQ4;GUP
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MWA .L9?!]:MZ+<V!'6)!?R)ABA)QZLV1V!$?\33UDCG,"<ES>"J/?#FR49"
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MN2\ #HA\  FIF!'Z5(E'P"!;UPC-W@@  ,!:?)6@%,AN_G7$::Y\8($$<0%
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M\?/&X>?=5?AY[QD_K\3/A93#M1[% #!@7J!U<M2@CRQ"3P\(\E0:YJC4XAG
M!T1)FAX0(AL>1)&H8,D4\$Q6@/.1\%Q-/1]E9[VFB^9ACM@&7T PAL$!_SH
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MU7PLGV/7V;2"U9<J5.".,$U=L\@,@H,$L#="7_DVS->W_$;H-QNUA8@]U;L
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MC,R24+7(!,*9'KPP0$0*>T=+"HV<[,;C@U15@Z9Q3J 0=^,'R:(OO05VDN$
M4C+]]08OLAW4G7=>]CLC_!B63YDE":.FS9ML_R_ >#?Y#0NOUVS7Z[=,(C&
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M.N#"/;)'Y5C _\/6ST6PES(=\[/YV]_ZB'DS?V+3)?\ 4$L! A0#%     @
M*HBZ5F28]SSR#P  9FH   X              ( !     &0T-C@S-3%D.&LN
M:'1M4$L! A0#%     @ *HBZ5MR-"@IG?P  FFL# !$              ( !
M'A   &0T-C@S-3%D97@Y.3$N:'1M4$L! A0#%     @ *HBZ5IDK;+UB)0
M\\\  !$              ( !M(\  &0T-C@S-3%D97@Y.3(N:'1M4$L! A0#
M%     @ *HBZ5JI[3X(B!   'Q$  !               ( !1;4  '=B82TR
M,#(S,#4R-BYX<V102P$"% ,4    "  JB+I6US4_\>4%  !T-0  %
M        @ &5N0  =V)A+3(P,C,P-3(V7V1E9BYX;6Q02P$"% ,4    "  J
MB+I6&J=4)_ '  #_6   %               @ &LOP  =V)A+3(P,C,P-3(V
M7VQA8BYX;6Q02P$"% ,4    "  JB+I6/E?P$)X%   ].0  %
M    @ '.QP  =V)A+3(P,C,P-3(V7W!R92YX;6Q02P4&      < !P"^ 0
&GLT

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
